pdf version

Transcription

pdf version

The News Magazine of the American Association of Colleges of Pharmacy
Academic Pharmacy
NOW
Jul | Aug | Sept 2010
Volume 3 Issue 3
There’s No Place Like the
Medical Home
American Association of
Colleges of Pharmacy
Discover · Learn · Care : Improve Health
table of contents
News in Brief
5
News Briefs
7
In Memoriam
9
Capitol Hill
News
Features
2010 AACP
Annual Meeting
Will
on
the
10
UH Hilo Receives
HIT Grant
14
Florida Researchers
Collect Samples in
the Keys
16
2010 Teachers of
the Year
47
Faculty News
22
Advancing
Science and
Stimulating the
Economy
32
Cau
Mem tion:
ber
Wor s at
k
Page 7: University of Washington School of
Pharmacy
Page 8: RDBscope; photo credit Steven Heller
Pages 12-13: Dr. Rosalie Sagraves, AACP Interim
Chief Science Officer
Page 15: University of Florida College of Pharmacy
Pages 20-21: Steve Schneider Photography
Page 25: The University of Toledo College of
Pharmacy
Back cover: istockphoto.com
academic Pharmacy now  Jul/Aug/Sept 2010
26
There’s No Place
Like the Medical
Home
Photo Credits
Page 23: University of Minnesota College of
Pharmacy
2
Leading By
Example
Front cover: istockphoto.com
Members
Working
for You
18
Hill
Faculty News
45
Expanding Our
Horizons
letter from the editor
Dear Colleagues:
Timing is everything, and by my observation, 2010 is a remarkable time in the history of our profession.
There is serious movement to reform the delivery and payment for healthcare in the U.S., not just due to
federal health reform legislation but because private payers and patients are tired of the old way of managing healthcare. Within these reform efforts the story is emerging clearly that, “You cannot have quality
healthcare without comprehensive pharmacy services.”
These are not my own words. I borrowed them from Jimmy R. Mitchell, recipient of the 2010 AACP Distinguished Service Award and former Director of the Office of Pharmacy Affairs (OPA) in the Health Resources and Services Administration. Under Jimmy’s leadership, the office launched clinical pharmacy
demonstration projects first and then several rounds of a patient safety and clinical pharmacy services
collaborative. Through this work, Jimmy, and OPA more broadly, became a major proponent for engaging
colleges and schools of pharmacy in the care of patients served by community health centers, HIV/AIDS
programs and other HRSA-supported health delivery systems that form the safety-net for caring for the
most vulnerable and underserved people in our society. In the third round of the patient safety collaborative, nearly 100 colleges and schools of pharmacy are engaged in making pharmacy services more widely
available. This is amazing community engagement and collaboration!
A hallmark of the work of OPA is the consistent manner of measuring and evaluating the impact of better medication management on patient outcomes. The evidence continues to accumulate throughout the
healthcare system that health improves and costs decrease when medication use is effectively managed.
Evidence also indicates that engaging pharmacists as medication use specialists is key to this improved
model of care.
In the reforms underway in 2010 and beyond, health policy leaders and other healthcare providers are
seeking answers to important questions, including how to increase the availability of primary care services.
Demand for such services is expected to grow dramatically as people who have previously found it difficult
to obtain health insurance find more affordable access to coverage. Recent reports from several AACP
standing committees examined the contributions to primary care access and quality that pharmacists, pharmacy faculty and student pharmacists could make. As in the work of the OPA, our analysis revealed substantial evidence that quality primary care requires integration of medication therapy management services
provided ideally by pharmacists. Numerous models of such services are documented in the literature.
Taking full advantage of the opportunities to integrate pharmacists and medication therapy management
into existing and emerging health delivery systems requires leadership from our schools, our faculties, our
alumni and our students. Armed with ample evidence that clearly shows how pharmacists truly make a difference in the outcomes of care, agents of change must work to help all the members of the patient-centered
health team become aware of what Jimmy Mitchell often repeats, “You cannot have quality healthcare
without comprehensive pharmacy services.”
Sincerely,
Lucinda L. Maine, Ph.D., R.Ph.
Executive Vice President and CEO
3
about us
Academic Pharmacy
NOW
2010 Classified Ad Rates
Classified Advertising Rates
(per insertion)
Full Page
Established in 1972 as AACP News, Academic Pharmacy
Now features comprehensive news stories that reflect
the discovery, learning and caring of more than 100 U.S.
colleges and schools of pharmacy. It is the only magazine focused strictly on the advancements of pharmacy
faculty and their students. The magazine is distributed
to all U.S. pharmacy institutions as well as more than
3,200 individual AACP members across the country.
Published quarterly as a membership service by the
American Association of Colleges of Pharmacy, Inc. For
address change, please return mailing label with current
school affiliation.
Corporate
and
Institutional
Members
Non-members
1 time
$2,600
$3,200
2 times
$2,160
$2,840
4 times
$1,720
$2,480
Corporate
and
Institutional
Members
Non-members
1 time
$1,500
$2,700
2 times
$1,160
$2,260
4 times
$820
$1,820
½ Page
©2010 by the American Association of Colleges
of Pharmacy. All rights reserved. Content may not
be reprinted without prior written permission.
We welcome your comments.
Executive Vice President/Executive Editor
Digital Requirements
Lucinda L. Maine
Academic Pharmacy Now supports a digital workflow and requires digital
ad submission. Ads must be submitted as press-ready pdf files or tiff
files. Fonts and images must be embedded. All images must be saved as
at least 300 DPI @ 100% of finished size. Ads may be submitted as grayscale or 4-color CMYK. Full-page ads run 8.5� by 11� with a full bleed;
half-page ads run 5.5� by 8.5� with a two-sided bleed. For any questions
on ad requirements, e-mail Tricia Ekenstam, art director, at tekenstam@
aacp.org. To submit advertisements, simply e-mail ads directly to Rebecca
Morgan, senior editor, at [email protected] or Maureen O. Thielemans,
managing editor at [email protected].
Senior Editor
Rebecca M. Morgan
[email protected]
Managing Editor
Maureen O. Thielemans
[email protected]
Art Director
Tricia Ekenstam
Issuance & Closing Dates
Frequency: 4 issues a year
American Association of Colleges of Pharmacy
1727 King Street
Alexandria, VA 22314
703-739-2330• Fax: 703-836-8982
www.aacp.org
Issue Closing Date
Jan/Feb/Mar
December 15, 2010
Apr/May/Jun
March 15, 2011
Jul/Aug/Sep
Oct/Nov/Dec
4
June 15, 2011
September 15, 2011
news in brief
News Briefs
UT Austin Pharmacy Professor
Developing New Vaccine Delivery
Systems
Pharmacy and Touro’s Master of Science degree program.
“HealthStart!” will teach health literacy and pharmaceutical
safety to Harlem students, grades pre-K–2, as well as to their
parents and teachers, using various learning tools including
Multidisciplinary researchers from The University of Texas at video, school lesson plans, hands-on interactive sessions and
Austin (UT Austin) College of Pharmacy and College of Natu- community outreach. The program is scheduled to launch at
ral Sciences are joining forces at a new pediatric research facil- P.S. 197 in Harlem in the fall with an animated video and supity to make an impact on children’s health challenges.
port materials designed for early and pre-readers.
A member of that team is Dr. Zhengrong (Rong) Cui, who re- “The goal is to create a program that can be used in other Harcently joined the UT Austin College of Pharmacy faculty. Cui is lem schools, and eventually throughout the entire country,” said
developing a novel model for the delivery of vaccines through Stuart Feldman, Ph.D., dean of the Touro College of Pharmacy,
the skin and he believes that not only will this be less painful noting that in addition to classroom instruction, students will
for children, but it also has the potential to deliver a more ef- be brought to the Touro-Harlem Medical Library and the Touro
fective vaccine.
College of Pharmacy for interactive group learning sessions.
“Vaccines are extensively given to children to promote the development of immunity against infectious diseases, and any development of new vaccines and alternative, non-invasive routes
of vaccination would be very beneficial,” said Cui, an associate
professor of pharmaceutics.
“The skin has evolved to protect not only by acting as a physical
barrier, but also by its role in our powerful immune system,” he
added. Cui also is working to develop nanoparticles and using
them as delivery systems for vaccine antigens or small molecular anti-cancer chemicals.
Touro-Harlem Medical Library Awarded
Prestigious Grant
The Touro-Harlem Medical Library has been awarded a competitive $30,000 grant to create a health literacy program for
underserved populations. “HealthStart!” is being developed by
the Touro-Harlem Medical Library, the Touro College of Pharmacy and “Project Aspire,” a public health initiative of the Children’s Health Education Foundation at Touro College.
The video will be developed by seven-time Emmy award winner
Ian Ellis James, who created the Hip Hop Stroke video for the
National Stroke Association and Harlem Hospital.
Albany College of Pharmacy and
Health Sciences Professor Receives
$1.4M Grant to Study Septic Shock
Dr. Arnold Johnson, a professor at Albany College of Pharmacy
and Health Sciences, has been awarded a four-year grant from
the National Institutes of Health in the amount of $1.4 million
to study lung inflammation associated with septic shock.
Septic shock is a dangerous bodily response to infection that
has a 40 percent mortality rate, affects five to ten percent of intensive care unit patients and causes more than 200,000 deaths
each year.
Infections, especially in cases such as pneumonia, appendicitis and meningitis, can lead to septic shock wherein patients
develop low blood pressure and organ injury. Septic shock is
treated with antibiotics and often requires blood-pressureraising drugs and mechanical ventilation.
Funding for the new program will be provided by the National
Library of Medicine, National Institutes of Health and the Department of Health and Human Services. The library is one of “Our research will study the lung response to various disease
only two institutions in the mid-Atlantic region to be awarded states with the goal of improving cell function and preventing
such a grant.
lung injury,” Johnson said. “The number of people who die
from septic shock has doubled in the last 20 years because of
The Touro-Harlem Medical Library, which opened in Sepseveral factors, including an aging population, an increasing
tember 2007, provides information and resources in the areas
reliance on strong, immune-weakening drug therapies and the
of basic science, bio-medicine, health, pharmacy and public
growth of antibiotic-resistant bacteria.”
health to support the curriculum and research goals of the
Touro College of Osteopathic Medicine, the Touro College of
5
news in brief
Massachusetts Pharmacy School and
Health Center Partnership Improves
Care
Massachusetts College of Pharmacy and Health SciencesWorcester/Manchester has partnered with Holyoke Health
Center (HHC), a private, nonprofit health center to provide
pharmacy services to the low-income and medically underserved populations of greater Holyoke, Mass.
Dr. Heather L. Upchurch, assistant professor of pharmacy
practice, and Tracey Cole, HHC pharmacy director, supervise
up-to-five Pharm.D. candidates every six weeks. As part of the
advanced experiential education rotation in ambulatory care,
student pharmacists are integrated with primary care and increase clinical pharmacy services to HHC.
Each student rounds with a primary care provider six hours
per week and performs pre-visit chart reviews and detailed
written consultations/SOAP notes to the providers. As part of
the patient’s primary care visit, the students perform medication reconciliation and are available to providers for specific
drug consults. Each student also assists in HHC’s Medication
Therapy Management clinic for high risk patients.
Since October of 2009, through Federal Capital Improvement
Program funding and a Health Resources and Services Administration expansion grant, more than $250,000 was invested to
open a second 340B pharmacy at the Chicopee Health Center
location in Chicopee, Mass. In addition, a second private consultation room, used for MTM visits, and technology upgrades
were added to the HHC pharmacy. An additional full-time
clinical pharmacist started July 1, which will increase access to
clinical pharmacy services for patients and allow for more student pharmacists to experience rotations at HHC.
UNC-Chapel Hill Pharmacy Education
Expanding to UNC Asheville
The University of North Carolina (UNC) Board of Governors
approved UNC-Chapel Hill’s plan to expand its pharmacy education program to UNC Asheville in partnership with Mission
Health System.
The UNC Eshelman School of Pharmacy in Chapel Hill will
create a satellite pharmacy program that will be based at UNC
Asheville. The program at UNC Asheville is an expansion of
the successful partnership the UNC-Chapel Hill pharmacy
school has had with Elizabeth City State University (ECSU)
since 2005.
The start-up costs for the program will be covered by a $2.5
million fundraising initiative spearheaded by the Asheville
Area Chamber of Commerce. By the fourth year of the program,
its cost is projected to be fully covered by tuition and by Mission Health System funding half the clinical faculty’s salaries.
The partnership program should not require any state funding.
Like its counterpart at ECSU, the satellite program at UNC
Asheville will educate more pharmacists in an area of North
Carolina that doesn’t have enough healthcare providers in
general. The UNC Eshelman School of Pharmacy recognized
the need for more healthcare practitioners in western North
Carolina through workforce research undertaken by the UNC
Cecil G. Sheps Center for Health Services Research and made
expansion into the area part of its strategic plan five years ago.
The satellite program could enroll up to 40 Doctor of Pharmacy students a year.
New Members Join AJPE Editorial Board
Three new editorial board members have been appointed to
the American Journal of Pharmaceutical Education. The Board
members beginning their three-year terms are Alicia S. Bouldin,
research associate professor at The University of Mississippi
School of Pharmacy; Dr. Brent Fox, assistant to the dean for
educational technology at Auburn University Harrison School
of Pharmacy; and Dr. Catherine A. Elstad, clinical associate
professor and associate dean of student services at Washington
State University College of Pharmacy. They will join Dr. Naser
Z. Alsharif (Creighton University), Dr. Shelley L. ChambersFox (Washington State University) and Dr. Peter D. Hurd (St.
6
Louis College of Pharmacy), who have been reappointed for
three-year terms, and 16 continuing members of the Board.
Board members serve as reviewers for manuscripts, write editorial viewpoints, serve as guest editors, review Journal performance and recommend to the editor topics that would be of interest to Journal readers. Board members completing their terms
are Dr. Timothy S. Tracy (University of Minnesota), Nicholas
G. Popovich (University of Illinois at Chicago) and Kristin K.
Janke (University of Minnesota).
news in brief
Purdue Radio Program Focuses on ‘Engineering Pharmaceuticals’
The life-saving potential—and soaring cost—of developing new
drugs is the subject of the third installment of Purdue University’s Global Challenges radio series, a collection of programs
designed to spotlight the role of engineering and other disciplines in solving pressing global challenges.
Yet, he’s survived a disease for five years that only 30 years ago
killed 100 percent of its victims.
“Engineering Pharmaceuticals” has been produced by the Purdue University College of Pharmacy, College of Engineering
and WFYI Public Radio in Indianapolis.
Researchers whose work is highlighted in the program include
Dr. Marietta L. Harrison, professor of medicinal chemistry
and molecular pharmacology and director of the Oncological
Sciences Center at Purdue; Dr. Charles Buck, director of operations at Purdue’s Bindley Biosciences Center; Dr. Gintaras
“Rex” Reklaitis, professor of chemical engineering at Purdue;
and Dr. Fernando Muzzio, professor of chemical engineering
at Rutgers, The State University of New Jersey, partners in a
National Science Foundation-funded program to improve the
pharmaceutical manufacturing process.
The program, narrated by Barbara Bogaev, former host and
editor of “Weekend America,” looks at the science and technology being used in the hunt for new drugs targeted to very
specific forms of disease. It explores the labyrinthine process of
gaining approval from government regulators and it follows the
path of those who figure out how to manufacture new drugs for
efficacy and safety.
Much of the program centers on the experiences of Matt Grossman, a freshman at Landmark College in Putney, Vt. Five years
ago, a few weeks after his bar mitzvah, Grossman was diagnosed
with a brain tumor. The list of drugs he has been given is long
and frightening. The drugs have left him with problems such as
trouble processing information. That’s why he’s at Landmark,
a college designed for youths with problems like cognitive deficits, dyslexia and attention deficit hyperactivity disorder.
“To be quite honest, if I hadn’t had chemo, I probably would
have been dead,” he says on the program.
Among others interviewed are Jeff Hatfield, CEO of Vitae Pharmaceuticals; Dr. Jerome Kassirer, former editor-in-chief of the
New England Journal of Medicine, who gives a critical view of
the pharmaceutical industry; and Craig Lustig, a cancer survivor and cancer patient advocate.
“Engineering Pharmaceuticals” is available online at http://
www.pharmacy.purdue.edu/radio.php and is being broadcast
nationally on public radio stations.
In Memoriam
Nathan A. Hall
Dr. Nathan A. Hall, former professor of pharmacy
at the University of Washington (UW), died June 2
after suffering a stroke. He was 92. Dr. Hall entered
UW at the age of 16 and graduated summa cum
laude at age 19. He served in the U.S. Army during
World War II. He earned his Ph.D. in pharmacy at
UW, married Florence Turnbull in 1960, and was a
professor of pharmacy at the university until his retirement in 1981.
“Dr. Hall was my undergraduate mentor; he had a
major influence on my career and research,” said Dr.
William L. Hayton, UW Class of 1967 and now associate dean of the College of Pharmacy at The Ohio
State University. “I was a participant in the NSFsponsored Undergraduate Research Program and
was in his lab at Bagley Hall from 1965-67. We conducted drug absorption studies using a fish model.
One of our published papers based on this work won
a Lunsford Richardson Pharmacy Award. The cash
was applied to purchase a 1966 Buick!” He added,
“Dr. Hall was instrumental in getting me to go to
graduate school. I was very lucky to have known him
and to have received his guidance.”
In 1959, Hall was awarded a Fulbright Senior Lectorship to the University of Malay in Singapore. In 1968,
he took a sabbatical to serve as visiting professor of
pharmacy at the University of Sydney in Australia.
He and his wife enjoyed traveling. According to Dr.
Wendel L. Nelson, who knew him before and during
his long retirement, Hall was “very competitive, and
very good” at sports, including bowling, handball
and golf, “which he played right into his 90s.”
Hall is survived by his children, Dennis and Pamella,
seven grandchildren, and his brother, Gregory. He
will be missed by his many friends and admirers in
the School of Pharmacy and the Academy, and he
will be long remembered for his contributions to science at UW.
7
news in brief
USC Pharmacy Faculty Member
Honored at White House
Dr. Roberta Diaz Brinton, director of the University of
Southern California (USC) Science Technology and Research
Program, was presented with the prestigious 2010 Presidential
Citizens Medal by President Barack Obama in a ceremony at
the White House on Aug. 4.
“What unites these citizens—what makes them special—is the
determination they share to find a wrong and right it; to see a
need and meet it; to recognize when others are suffering and
take it upon themselves to make a difference,” said President
Obama at the ceremony.
Considered among the nation’s highest civilian awards, the
Presidential Citizens Medal recognizes citizens who have
performed exemplary deeds of service for the nation. Twelve
other citizens were honored along with Brinton, having been
chosen from a pool of some 6,000 applicants.
Brinton was recognized for her work in improving science and
technology education for students in Los Angeles through
the USC Science Technology and Research program, known
as STAR, for the last 22 years. The program provides elementary, middle and high school students and their teachers with
unique access and tools that are structured to engage students
in science.
experiments, using research technologies and even working
on journal articles. Ultimately, the experience gives these
students a high-level science background, which gives them
stellar experiential training when applying to colleges and, in
many, igniting a lifelong interest in science and in mentoring
future generations.
The STAR program has served thousands of minority and
disadvantaged children in the Los Angeles area over the past
two decades. Those who went through the secondary school
lab experience have had a 100 percent rate of attending and
completing college. Many of the students who participate in
the program are the first in their families to attend college.
While Brinton has been a stalwart director of STAR, she
also runs an impressive research enterprise at the School of
Pharmacy, where she holds the R. Pete Vanderveen Chair in
Therapeutic Discovery and Development. Her work focuses
on neurodegeneration, with an emphasis on Alzheimer’s
disease. Recently, a compound to prevent or delay Alzheimer’s
disease discovered in her lab was funded for a clinical trial by
the National Institutes of Health.
“I am very grateful for this honor,” Brinton said. “And I
especially want to thank USC President C. L. Max Nikias,
President Emeritus Steven Sample and School of Pharmacy
Dean R. Pete Vanderveen for their persistent support of this
program and its outreach into our community.”
A cornerstone of the program is the opportunity for high
school students to become working members of research
teams in labs throughout USC.
As an embedded portion of their secondary school curriculum, these students are in the lab daily, conducting
Dr. Roberta Diaz Brinton,
director of the University of
Southern California Science
Technology and Research
Program, received the prestigious 2010 Presidential Citizens Medal by President Barack Obama in a ceremony at
the White House on Aug. 4.
8
Capitol Hill News
news oin n brief
Will
by Will Lang
the
Hill
Heavy Lifting Ahead
The passage of the Patient Protection and Affordable Care
Act of 2010 (PPACA) [1] may have seemed like heavy work,
but implementation of its hundreds of provisions will pale in
comparison. Yet, the opportunity for advancing the vision of
the pharmacist as an integral member of the healthcare team
outweighs the challenges of implementation. The legislation reflects decades of patient, provider and policy expert
interest in increasing access to care that is affordable and
of high quality. Addressing the quality issue is where provisions that discuss coordination of care and determine the
effectiveness of care intersect. While many of these quality
provisions will be initially implemented as demonstrations
and pilot projects, the opportunity for these models of care
to become the standard of care are clearly delineated in the
law. Pharmacy faculty can and should play an important role
in collaborating in the development, implementation and
evaluation of these demonstration and pilot projects.
As mentioned above, improving the quality of healthcare, especially by improving care coordination, is a primary implementation concern of healthcare reform. It is a disappointing
and often life-threatening aspect of our current healthcare
system that a patient’s care is a scatter-shot attempt to improve health outcomes. Multiple providers attempting to
provide care within multiple healthcare facilities without sufficient feedback places a patient in jeopardy of unsatisfactory care and our economy in jeopardy due to unnecessary
care. Within the healthcare reform legislation are many provisions that will, over time, attempt to improve patient care
and reduce costs. Of particular interest are the provisions
that will help create a better-coordinated, patient-centered,
team-based approach to care, which is supported by health
information technology, and are the legislative expression
of recommendations in reports and statements of a number
of health policy, delivery and quality organizations [2], [3],
[4], [5],[6].
The medical home, or more appropriately called the patientcentered medical home (PCMH), is the model most frequently
equated with improving the coordination of a patient’s care.
The PPACA includes provisions that authorize the development, implementation and evaluation of PCMH models. The
Center for Medicare and Medicaid Innovation, authorized
within Section 3021 of the law, will be responsible for selecting models that include “promoting broad payment and
practice reform in primary care, including patient-centered
medical home models for high-need individuals, medical
homes that address women’s unique healthcare needs, and
models that transition primary care services away from feefor-service based reimbursement and toward comprehensive payment or salary-based payment.”
Improving the quality of care through improved coordination models such as the medical home is already an area
of research and service for some pharmacy faculty. The
implementation of healthcare reform legislation provides
ample opportunity for academic pharmacy to advance improvements in patient care through the integration of clinical pharmacy services envisioned in the move to the Doctor
of Pharmacy as the professional degree. It is essential for
faculty members who are engaged in such endeavors to
communicate this engagement with AACP staff and public
policy experts to influence how models are developed and
evaluated. Faculty members not engaged will be doing the
public, students, the pharmacy profession and their institutions a disservice if they remain on the sidelines since models of care will ultimately lead to some models becoming
the standard for future healthcare delivery. The community
outreach will require substantial effort. Pharmacy faculty
need to immediately engage with state Medicaid programs
and medical societies to develop relationships and help
overcome bias and preconceived ideas of what it takes to
improve the quality of care. This edition of Academic Pharmacy Now includes articles that provide some framework
for successful engagement that will help make the heavy
lifting just a little easier.
Build and strengthen your academic pharmacy advocacy
portfolio by visiting AACP’s Web site at www.aacp.org/
issuesandadvocacy/advocacy/AdvocacyInAction.
The following citations are sources of information regarding the
patient-centered medical home:
[1] Patient Protection and Affordable Care Act of 2010, Public Law 111-148,
http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=111_cong_
bills&docid=f:h3590pp.txt.pdf
[2] Health Professions Education: A Bridge to Quality, April 8, 2003, Institute of Medicine http://www.iom.edu/Reports/2003/Health-ProfessionsEducation-A-Bridge-to-Quality.aspx
[3] Patient-Centered Primary Care Collaborative www.pcpcc.net
[4] HRSA Patient Safety and Clinical Pharmacy Collaborative www.hrsa.gov/
patientsafety
[5] Institute for Healthcare Improvement www.ihi.org
[6] National Committee for Quality Assurance www.ncqa.org
9
news in brief
University of Hawaii at Hilo College
of Pharmacy Awarded $16 Million
for Healthcare Pilot Project
A consortium led by the University of Hawaii at Hilo (UH
Hilo) College of Pharmacy to use health information technology to provide better healthcare to Big Island residents has
been awarded $16,091,390. The funds were awarded through
a grant from the U.S. Department of Health and Human Services, which is funded by the American Recovery and Reinvestment Act.
Hawaii County is one of 17 communities across the nation chosen to serve as pilot communities to develop wide-scale use of
electronic medical records through the Beacon Communities
program.
“Given the geography of the Big Island, getting in to see a
healthcare professional can be difficult for some residents,”
said Sen. Daniel K. Inouye. “In order to maximize this precious
time with patients, healthcare professionals need immediate
access to up-to-date information in order to properly diagnose
and treat the patient. Integrating our vast network of public
and private healthcare professionals in Hawaii is vital to ensuring that patients receive the highest quality of care. Health
information helps ensure that patients are receiving care that
accounts for every aspect of their medical history.”
The UH Hilo College of Pharmacy is the lead applicant organization for the grant from the Hawaii County Beacon Community Consortium, a group of educators, healthcare providers, insurers and other community members. The group was
formed to strengthen and use health information technology
to continuously improve healthcare quality, cost-efficiency and
population health in Hawaii County.
“This award is particularly monumental for bringing in money to the state and the significant improvement in serving the
healthcare needs of patients in Hawaii,” said Dr. John M. Pezzuto, dean of the College of Pharmacy. “We’re pleased that
the UH Hilo College of Pharmacy could take a leading role in
this initiative, which demonstrates the strength of partnerships
throughout the state at all levels.”
10
UH Hilo Chancellor Dr. Rose Tseng said she is pleased to join
with so many community partners in this important effort to
improve healthcare on the island.
“Many of our island’s dedicated medical leaders are coming together to advance this goal and I truly believe that, when we
all work together, great things can happen,” Tseng said. “This
group will maximize the potential of information technology to
lower the cost and enhance the quality of care for our island.”
The effort will concentrate on the implementation of a regionwide Health Information Exchange and Patient Health Record
solution. The system will use secure, Internet-based care coordination and tele-monitoring tools to increase access to specialty care for patients with chronic diseases such as diabetes
and hypertension, the White House announcement said.
Karen L. Pellegrin, director of strategic planning for the College of Pharmacy, said the project would not be possible without tremendous effort and staff time from businesses in the
community such as KTA and T&T Electric, as well as members
of the consortium.
“Given an extraordinary level of community engagement and
stakeholder leadership at the highest levels, the College of
Pharmacy is honored to work alongside these other community leaders,” Pellegrin said. “Our goals are to improve prevention of disease, improve access to appropriate care and reduce
health disparities for Hawaii Island residents.”
news in brief
U of M Study Shows Targeting the
Blood-brain Barrier May Delay
Progression of Alzheimer’s Disease
University of Minnesota (U of M) researchers may be one step
closer to slowing the onset and progression of Alzheimer’s disease.
with a steroid-like chemical that activates PXR, the amount of
beta-amyloid protein in the brain is reduced. The activation of
the PXR was found to increase the expression of a blood-brain
barrier protein called P-glycoprotein. This protein transports
beta-amyloid out of the brain.
A study that appears in the May issue of Molecular Pharmacology shows that by targeting the blood-brain barrier, researchers from the College of Pharmacy and the National Institute “We know that P-glycoprotein levels are reduced in the bloodof Environmental Health Sciences were able to slow the accu- brain barrier in Alzheimer’s patients, and we now have demonmulation of a protein associated with the progression of the strated that P-glycoprotein may play a pivotal role in clearing
beta-amyloid from the brain” said Dr. Bjoern Bauer, assistant
illness in mice.
professor at the College of Pharmacy and senior author of the
The researchers say this study may provide the experimental paper.
basis for new strategies that can be used to treat Alzheimer’s
“When we treated the Alzheimer’s mice with a chemical that
patients.
activates PXR, blood-brain barrier P-glycoprotein increased,
The blood-brain barrier is the brain’s main defense system—it and beta-amyloid brain levels in the mice reduced by as much
separates the brain from the rest of the body’s blood supply. as 60 percent within seven days to the levels of healthy mice,”
The barrier both prevents harmful toxins in the blood from en- he said.
tering the brain and removes harmful toxins that are byprodIt is possible that reduced P-glycoprotein expression at the
ucts of chemical reactions in the brain.
blood-brain barrier may be an early indicator of Alzheimer’s
Alzheimer’s disease is an irreversible, progressive brain disease disease, even before the cognitive symptoms appear and that it
that slowly destroys memory and thinking skills, and eventu- contributes to beta-amyloid accumulation in the brain, said Dr.
ally disrupts function of major organs. Estimates vary, but ex- Anika Hartz, lead author on the paper and research associate in
perts suggest that as many as 2.6-5.1 million Americans may the Department of Biochemistry and Molecular Biology at the
have Alzheimer’s.
U of M Medical School, Duluth campus.
One hallmark of Alzheimer’s is the deposition of beta-amyloid
protein in the brain. This protein clumps to form plaques that
destroy neurons. Neuron loss leads to cognitive impairment
and memory loss.
One of the challenges confronting the diagnosis and treatment
of Alzheimer’s is being able to clearly diagnose the disease process when brain damage is minimal, before any symptoms occur.
In this study, the researchers were able to reduce the accumulation of beta-amyloid protein in the brain by targeting a certain
receptor in the brain known as the pregnane X receptor, or
PXR.
The researchers plan to conduct a study where the Alzheimer’s
mice are fed a PXR-activating compound in their diet for 12-18
months. The cognitive skills of the animals will be monitored
regularly, along with their P-glycoprotein levels, to determine
whether the feeding regimen delays the onset of cognitive impairment.
When researchers treated genetically modified mice that model
human Alzheimer’s disease (developed by Dr. Karen H. Ashe,
professor in the Department of Neurology and Neuroscience)
11
news in brief
AACP Co-Sponsors VII Pan American
Conference on Pharmaceutical Education
T
he VII Pan American Conference
on Pharmaceutical Education,
co-sponsored by the Pan American Health Organization (PAHO) and
AACP, was held May 24–26, 2010 in
Porto Alegre, Brazil. Participants came
from more than 20 countries in Central,
North and South America, as well as the
Caribbean islands.
The theme of the 2010 Pan American
Conference was Competency-Based
Training. The conference executive
committee selected a format of workshops and discussions with only a few
presentations so that attendees could
have multiple opportunities to participate. One set of workshops allowed for
discussion of the accreditation document on pharmaceutical education,
Proposal for Accreditation of Pharmacy
Careers in Latin America. Another
set of workshops enabled participants
to discuss the Basic Pharmaceutical
Education Plan for the 21st Century, a
curricular plan that was developed during previous Pan American Conferences
and refined over time. Other workshop
topics included Reflection on the Role
of the Pharmacist and Training Orientation; a Permanent Forum for Discussion
and Proposals for Pharmaceutical Education: Is It Necessary?; and, Technologies for Communication, Education and
Networking.
would allow for more coordination of
the organization between conferences.
Dr. José Luis Castro, PAHO consultant,
and members of the executive committee will determine the type of individual
needed for the position and begin the
hiring process.
The Pan American Commission for
Pharmaceutical Education held its
business meetings during the conference. The commission is composed of
one delegate from each country in the
Americas that was represented. Mexico
was selected to host the 2012 conference and Cuba in 2014. Conference organizers hope that a significant number
of AACP members will attend the 2012
Pan American Conference in October
2010 and will support our Mexican colleagues as they host the meeting. More
information about that conference will
be available via AACP and its Global
Pharmacy Education SIG.
AACP members who participated in
the 2010 Pan American Conference included Dr. Magaly Rodriguez de Bittner,
head of the Department of Pharmacy
Practice at the University of Maryland
Host country members presented their
viewpoints about the role of pharmacists in a governmental healthcare
system during a roundtable discussion titled “Integration of Health Care
within the Teaching Experience–The
Experience of Brazil.” By the close of
the conference, delegates agreed that
much had been accomplished in the
areas of accreditation and curriculum planning, and it was determined
that the Pan American Conference
on Pharmaceutical Education should
become more structured. This would
start with the hiring of an individual
to be a permanent secretary, which
12
School of Pharmacy; Mike Rouse, assistant executive director, international
& professional affairs, Accreditation
Council for Pharmacy Education; and
Dr. Rosalie Sagraves, dean emeritus and
professor emeritus at the University of
Illinois at Chicago College of Pharmacy
and consultant in Global Pharmacy
Education for AACP. Rodriguez de
Bittner represents AACP on the Pan
American Commission for Pharmaceutical Education, and as a member of
the Conference Executive Committee,
and led several workshop sessions and
discussions during the conference.
Mike Rouse represented the International Pharmaceutical Federation
(FIP) Pharmacy Education Taskforce
Advisory Group and is project leader
for Quality Assurance. He updated
attendees concerning the taskforce’s
work and its future plans for global
pharmacy education, as well as sharing
information concerning advancements
in quality assurance. Sagraves presented
an update on global pharmacy education from an AACP perspective and
spoke of how the Pan American Conference could become a more formalized
The 2010 Pan American Conference, held in Porto Alegre, Brazil,
focused on competency-based
training and featured workshops
that discussed wide-ranging topics such as the accreditation document on pharmaceutical education,
the Proposal for Accreditation of
Pharmacy Careers in Latin America
and the Basic Pharmaceutical Education Plan for the 21st Century, a
curricular plan that was developed
during previous Pan American Conferences and refined over time.
news in brief
organization and a future member of
the Global Alliance for Pharmacy Education (GAPE), a recently organized
group of pharmacy education associations around the globe.
In addition to attending the VII Pan
American Conference on Pharmaceutical Education, some attendees,
including those from the U.S., attended
several functions of the XX Pan-American Pharmacy Congress, which was
also held in Porto Alegre. Rodriguez de
Bittner was an invited speaker at the
Congress and spoke about the Maryland P3 (Patients, Pharmacists, Partnerships) Program, which is a program
for self-insured employers that provides
pharmacist coaches who help employees manage their chronic disease(s). For
this program, Rodriguez de Bittner and
her University of Maryland colleagues
were recipients of one of the 2010
Pinnacle Awards, which are presented
annually by the American Pharmacists
Association Foundation.
Dr. Magaly Rodriguez de Bittner,
head of the Department of Pharmacy Practice at the University of
Maryland School of Pharmacy, and
Alejandro Nieto Rodriguez, executive director of the Mexican Association of Pharmacy Schools.
13
news in brief
“It’s the biodiversity
that makes the
Florida Keys a hot
spot for researchers,”
Luesch said.
14
University of Florida Marine
Researchers Collect Samples
Amidst Growing Oil Threat
As the oil spill in the Gulf of Mexico steadily migrated toward
Florida last June, University of Florida (UF) marine researchers hurried to collect underwater marine algae samples in the
Florida Keys.
Dr. Hendrik Luesch, an associate professor of medicinal
chemistry at the UF College of Pharmacy, took his research
team to Long Key in hopes of advancing early drug discoveries that may yield cancer-fighting properties hidden in marine
algae. It’s an expedition he has made annually for four years,
but this year it seems there might be a limit on how long the
ecosystem will yield its specimens.
According to scientists, nearly five million barrels of oil were
released into the Gulf of Mexico after the Deepwater Horizon
oil rig explosion on April 20.
“Cyanobacteria, or organisms that overgrow coral reefs, are
shown to produce drug-like compounds that may be exploited
for biomedical purposes such as anti-cancer drugs,” Luesch
said.
The warm waters and mild year-round temperatures allow
marine life to flourish in the Keys, creating a predatory environment among these organisms, Luesch said. In order to survive, marine organisms develop defense systems, sort of like a
chemical survival kit. Researchers use these toxic chemicals as
the basis for creating drugs that can target and fight cancers.
“It’s the biodiversity that makes the Florida Keys a hot spot
for researchers,” Luesch said.
At the same time,
the coral reefs are
also a very sensitive
ecosystem, he said.
For example, the
extended chill in
the tropical waters
last January caused
sea turtles to become cold-stunned
and killed more
than 85 percent of reefs in certain areas, according to Cynthia
Lewis, a biological scientist at the Keys Marine Laboratory in
Long Key, where the UF researchers collected specimens.
Scientists in Florida don’t know what to expect, she said.
“We are concerned and watchful,” she added. “We don’t know
how far the marine impact may go.”
Lewis and nine other scientific teams under the Florida Fish
and Wildlife Conservation Commission took baseline samples
on the Gulf and Atlantic coasts from Key Largo to Key West to
establish pre-impact marine wildlife assessments, she said.
One challenge with his research, Luesch noted, is the randomness of finding an organism and the length of time it takes to
isolate and test a compound for its specific drug-producing
qualities. Environmental variables may change, which means
the organism may change as well.
“We may find an interesting species, but it takes months of
research just to isolate the active compound and analyze the
properties in our lab,” Luesch said. “Attempts to re-collect
often fail because we do not always see the same organism
again.”
Two compounds from the oceans have been developed into
drugs that are on the market today—one treats cancer, and
the other is a pain reliever. Fourteen more are in clinical trials.
Scientists simply don’t know how many biological organisms
are in the ocean, Luesch said, but marine organisms often
produce multiple compounds, and he estimates that more
than 90 percent have not yet been discovered.
What does the largest-ever oil spill disaster mean to Luesch
and his research?
“I am thinking what everyone else in the United States and in
the world is thinking—what a catastrophe this is for mankind
and especially the area in the Gulf of Mexico,” he said. “Secondly, I am concerned for the marine discovery efforts by our
groups and other groups in this area.”
Dr. Hendrik Luesch, associate professor of medicinal chemistry at
the University of Florida College of Pharmacy, sorts through the
day’s diving samples of blue-green algae on June 10, 2010, during an
expedition to the Florida Keys. Along with members of his UF marine
natural products lab, Luesch raced toacademic
collect new Pharmacy
samples as envinow  Jul/Aug/Sept 2010
ronmental impacts from the migrating oil spill threatened Florida.
15
news in brief
2010 Teachers of the Year
Each year, AACP member institutions submit their Teachers of the Year for
recognition at the Annual Meeting and Seminars. This year’s honorees were
feted at a special luncheon and at the Closing Banquet of the 2010 Annual
Meeting in Seattle. AACP congratulates the 2010 Teachers of the Year:
Albany College of
Pharmacy and Health
Sciences
Dr. Ray Chandrasekara
Dr. Jeffrey M. Voigt
Appalachian College of
Pharmacy
Dr. Charles R. Breese
Dr. Sarah T. Melton
Auburn University
Dr. Erika L. Kleppinger
Butler University
Dr. Alexander J. Ansara
Dr. Kimberly M. Beck
California Northstate
College of Pharmacy
Dr. Leanne Coyne
Creighton University
Dr. Karen K. O’Brien
Dr. Victoria F. Roche
Drake University
Dr. Sarah E. Grady
East Tennessee State
University
Dr. Stacy D. Brown
Dr. Brian L. Odle
Dr. Victoria E. Ramsauer
Florida A&M University
Dr. Janet Barber
Ms. Tanaga A. Boozer
Dr. Charlie W. Colquitt
Dr. Tonya S. Martin
Dr. Leonard R. Rappa
Dr. Kinfe K. Redda
16
Hampton University
Dr. Deidre R. Payne
Husson University
Dr. Aaron M. Domina
Dr. David B. Romerill
Lake Erie College of
Osteopathic Medicine
Dr. Naushad K. Ghilzai
Dr. Lakhu Keshvara
Dr. Dolores A. Kutzer
Long Island University
Dr. Hamid Rahim
Massachusetts College
of Pharmacy and Health
Sciences-Boston
Dr. Erika Felix-Getzik
Dr. Dan Kiel
Massachusetts College
of Pharmacy and Health
Sciences-Worcester
Dr. Abir Kanaan
Midwestern University/
Downers Grove
Dr. Carrie A. Sincak
Northeastern University
Dr. Eugene A. Bernstein
Dr. Jason W. Lancaster
South Carolina College of
Pharmacy-USC Campus
Dr. Betsy W. Blake
Northeastern Ohio
Universities Colleges of
Medicine and Pharmacy
Dr. Dale E. English II
Dr. Kristen L. Longstreth
Dr. Sharanie V. Sims
South Dakota State
University
Dr. Daniel J. Hansen
Nova Southeastern
University
Dr. Kevin A. Clauson
Southern Illinois University
Edwardsville
Dr. A. Michael Crider
Dr. Keith A. Hecht
Oregon State University
Dr. David T. Bearden
Dr. Gary E. DeLander
Dr. Philip J. Proteau
Dr. J. “Fred” Stevens
Southwestern Oklahoma
State University
Dr. Tom W. Davis
Dr. Carroll L. Ramos
Pacific University Oregon
Dr. Pauline A. Cawley
Dr. Fawzy Elbarbry
St. Louis College of
Pharmacy
Dr. John M. Beale Jr.
Palm Beach Atlantic
University
Dr. Dana A. Brown
Texas A&M Health Science
Center
Dr. Lacy Daniels
Dr. Srikanth Kolluru
Dr. Mohammad T. Nutan
Regis University
Dr. Stephen W. Luckey
Midwestern University/
Glendale
Dr. Kimberly Cauthon
Dr. Stephanie J. Counts
Rutgers, The State
University of New Jersey
Dr. Joseph A. Barone
North Dakota State
University
Dr. Stephen T. O’Rourke
Pharmacy-MUSC Campus
Dr. Sarah P. Shrader
South University
Dr. Martin M. Zdanowicz
Texas Tech University
Health Sciences Center
Dr. Craig D. Cox
Dr. Reza Mehvar
Dr. Nikita Mirajkar
Dr. Quentin R. Smith
Dr. Sanjay K. Srivastava
The Ohio State University
Dr. Dennis B. McKay
Dr. Vinita B. Pai
news in brief
The University of Arizona
Dr. David A. Apgar
Dr. John W. Regan
The University of Texas at
Austin
Dr. Edward “Ted” M. Mills
The University of British
Columbia
Dr. Brian E. Cairns
Mr. Tamiz Kanji
Dr. Peter S. Loewen
Ms. Tessa Nicholl
Dr. Wayne Riggs
Mr. Tony T. Seet
The University of Toledo
Dr. Vincent F. Mauro
The University of Georgia
Dr. Brian D. Buck
Union University
Dr. Kim M. Jones
Dr. David A. Kuhl
Dr. Joel S. Owen
The University of Iowa
Dr. Robert F. Shaw
The University of Kansas
Dr. James M. Backes
The University of Louisiana
at Monroe
Dr. Benny L. Blaylock
Dr. David J. Caldwell
Dr. Jeffery D. Evans
Dr. Blair P. Wilbert
The University of
Mississippi
Dr. Brian L. Crabtree
Mr. Larry A. Krohn
Dr. David J. McCaffrey
Dr. Christopher R. McCurdy
Dr. Justin J. Sherman
The University of Montana
Dr. Douglas R. Allington
Dr. Keith K. Parker
The University of New
Mexico
Dr. Gretchen M. Ray
The University of
Oklahoma
Dr. Vincent C. Dennis
The University of
Tennessee
Dr. Shaunta’ M. Ray
Dr. Katie J. Suda
The University of Utah
Dr. James N. Herron
Touro University California
Dr. Eric Ip
University at Buffalo, The
State University of New
York
Dr. Peter M. Brody Jr.
University of Alberta
Dr. Nese Yuksel
University of Arkansas for
Medical Sciences
Dr. Russell B. Melchert
Dr. T. Scott Warmack
University of California,
San Francisco
Dr. Brad Colwell
Dr. Nam Do
Dr. Peter Forni
Dr. Andrea Iannucci
Dr. Jeffrey Lansman
Dr. Conan MacDougall
Dr. Marisa Mendez
Dr. Virginia Okabayashi
University of Cincinnati
Dr. Bradley E. Hein
University of Colorado
Denver
Dr. Douglas N. Fish
Dr. Brian A. Hemstreet
University of Connecticut
Dr. Charles M. White
University of Florida
Dr. Michael J. Meldrum
University of Hawaii at Hilo
Dr. Douglas Adriance-Mejia
Dr. Linda Connelly
Dr. Lara Gomez
Dr. Aaron Jacobs
Dr. Eugene A. Konorev
Dr. Supakit Wongwiwatthananukit
University of Houston
Dr. Aditi Marwaha
Dr. Lynn Simpson
University of Illinois at
Chicago
Dr. Bradley C. Cannon
University of Kentucky
Dr. James R. Pauly
Dr. Frank Romanelli
University of Maryland
Dr. Neha U. Sheth
University of Minnesota
Dr. Jeannine M. Conway
Dr. Timothy P. Stratton
University of MissouriKansas City
Dr. Steven C. Stoner
University of Nebraska
Medical Center
Dr. Edward “Ted” Roche
University of New England
Dr. Glenn W. Rosenthal
University of North
Carolina at Chapel Hill
Dr. Ralph H. Raasch
University of Pittsburgh
Dr. Kristine S. Schonder
University of Rhode Island
Dr. Anne L. Hume
University of Southern
California
Dr. Edward Lieskovan
Dr. Stan G. Louie
Dr. Veena Venugopalan
Dr. Michael Z. Wincor
University of the Incarnate
Word
Dr. Mark C. Granberry
University of the Pacific
Dr. Myo-Kyoung Kim
University of the Sciences
in Philadelphia
Dr. Lisa E. Davis
University of Toronto
Dr. Ian Crandall
Ms. Marie A. Rocchi
Dr. Debra Sibbald
University of Washington
Dr. Karan N. Dawson
Dr. Gary W. Elmer
Ms. Michaelene Kedzierski
Dr. Nanci L. Murphy
University of WisconsinMadison
Dr. Steven G. Oakes
University of Wyoming
Dr. Bruce W. Culver
Dr. Jennifer L. Petrie
Washington State
University
Dr. Catherine A. Elstad
Dr. Mark W. Garrison
Dr. Beth A. Vorderstrasse
Dr. John R. White Jr.
West Virginia University
Dr. David P. Elliott
Western University of
Health Sciences
Dr. Eric K. Gupta
Wilkes University
Dr. Jon D. Ference
Dr. Kenneth A. Pidcock
Dr. Adam VanWert
Wingate University
Dr. Samir A. Kouzi
Xavier University of
Louisiana
Dr. Yashoda V. Pramar
17
Pharmacy Educators
Expand Their Horizons
in Seattle at the 2010
AACP Annual Meeting
news in brief
18
More than 1,700 members of the Academy convened in the
Emerald City July 10–14 eager to attend the 2010 AACP Annual Meeting and Seminars. With highly informative special
sessions on faculty development, assessment and experiential
education, meeting attendees left armed with tools to continue
Expanding Our Horizons at their home institutions and ready
to shape the future of global healthcare.
“The 2010 AACP Annual Meeting continues to receive rave reviews from members, attendees, guests and exhibitors,” said
Dr. Lucinda L. Maine, AACP executive vice president and CEO.
“The event exceeded all expectations and we look forward to
continuing this trend next year in San Antonio.”
www.aacp.org/annualmeeting10
19
The Teachers Seminar kicked off the Annual Meeting on Saturday, July 10 as more
than 250 educators and students gathered
at the Sheraton Seattle Hotel to learn about
developing, implementing and sustaining interprofessional education. Attendees
listened to keynote speaker Dr. John H.V.
Gilbert, project lead for the Canadian Interprofessional Health Collaborative, as he
emphasized the importance of communicating “interprofessional,” which he described
as getting the right word and the word right.
Using The University of British Columbia
model of expose, immerse and master, Gilbert explained that through exposure, students should be allowed to develop a sense
of their profession and understand areas of
collaboration, while immersion in collaborative practice learning environments and
mastery of these skills after graduation or
licensure is critical. Following the morning’s
opening session, participants had the opportunity to attend several break-outs that
featured some of the country’s foremost experts on interprofessional education.
Donning matching t-shirts with the phrase
“Carter’s Crew” printed on the back, faculty
from the University of Minnesota claimed
victory at the Show Your School Spirit Welcome Reception, which officially kicked off
Annual Meeting festivities on Saturday evening. Dressed in maroon and gold, College
of Pharmacy Dean Dr. Marilyn K. Speedie
accepted the top prize on behalf of the more
than 20 Golden Gophers who showed support for the-President-Elect Dr. Rodney A.
Carter. Groups from The Ohio State University, The University of Oklahoma and Camp-
bell University embodied their school’s spirit
with matching shirts and decorative jewelry.
The reception also featured School Posters
addressing the topic of SALT: The Scholarship of Assessment, Learning and Teaching,
at which attendees could mingle and network with fellow pharmacy educators.
Tom Vander Ark, managing partner of
Revolution Learning and founding blogger
of www.EdReformer.com, spoke about The
Future of Learning at the Opening General
Session on Sunday, July 11. He enlightened
the standing-room-only crowd about the
concept of blended learning, a shift to online
delivery of education for at least part of the
day with the intention of making learning,
staffing and facilities more productive. The
model is designed to serve digital natives
and promote personalization, problem solving and critical thinking, all skills that are
essential to the education of today’s student
pharmacists.
Later that day, Vander Ark blogged about
the use of computer simulations and experiential learning in academic pharmacy, noting that the Academy appears to be leading
the way in the utilization of blended learning
in the classroom.
“… It’s clear that the ‘21st century skills’ conversation is alive and well at AACP. They are
thinking hard about how to prepare health
care professionals to work on teams, to communicate effectively, and solve problems for
patients.”
Programming at the 2010 Annual Meeting
explored new developments in pharmacy education and practice. More than 100 special
sessions provided attendees with an abundance of professional development opportunities. Sessions spanned four days and focused on innovative topics such as tailoring
teaching methods to millennial students and
building a winning global experience at colleges and schools of pharmacy. New to this
Top: Two Annual Meeting attendees discuss a poster
from the University of the Pacific during the AACP Welcome Reception and School Posters session.
Middle: AACP President Dr. Rodney A. Carter (middle)
and his family proudly wear t-shirts that read “Carter’s
Crew.”
Bottom: AACP Past President Dr. Victor A. Yanchick
(far right) leads a stimulating discussion of what marks
excellence in pharmacy education and research with
AACP’s top award winners: Paul R. Dawson Biotechnology Award recipient Dr. Harold L. Kohn (far left), Volwiler
Research Achievement Award winner Dr. Hartmut C.
Derendorf (second from left) and Robert K. Chalmers
Distinguished Pharmacy Educator Award winner Dr.
Mary Anne Koda-Kimble (second from right).
20
year’s meeting were three Webinars: Clinical
Reasoning Education: The Science and Craft,
the Roles of the Basic Sciences, presented by
the Pharmaceutics and Chemistry Sections,
as well as Pathways to Mentoring: Developing
Future Faculty Mentors and Business Meeting and Sustaining Departments of Pharmacy
Practice During Uncertain Economic Times,
both presented by the Pharmacy Practice
Section. All three Webinars are available on
the AACP Annual Meeting Web site at www.
aacp.org/annualmeeting10.
Attendees also had three opportunities to
peruse the record-number of research and
education posters that highlighted individual
and school research activities, while discussing the latest pharmacy education products
and services at each of the nearly 40 exhibitor booths. The new Exhibit Hall Passport
drew hundreds of meeting attendees to the
hall and provided them with a chance to win
fantastic prizes such as an iPad, a flat screen
TV, a Visa gift card and a complimentary
registration to the 2011 Annual Meeting in
San Antonio.
The Academy gathered together on Tuesday
night to celebrate its collective accomplishments. The Closing Banquet featured the
presentation of the Rufus A. Lyman Award
to authors Dr. Rosemin Kassam and Mona
Kwong from The University of British Columbia (UBC) for the best paper published
in the American Journal of Pharmaceutical
Education. The award recognizes a nearly
decade-long effort on behalf of Dr. Kassam’s
team at UBC to provide a meaningful and
evidence-based experience for her students,
one that has resulted in positive outcomes
for countless patients, she said.
Honoring his commitment and dedication to
patient safety, clinical pharmacy services and
collaboration with academic pharmacy, the
Distinguished Service Award was presented
to Jimmy R. Mitchell, former director of the
Office of Pharmacy Affairs in the Health Resources and Services Administration. Mitchell is co-chair of HRSA’s Patient Safety and
Clinical Pharmacy Services Collaborative and
Top: Dr. Anne Y. Lin, dean of the College of Notre Dame
of Maryland School of Pharmacy, talks about AACP’s
programs, products and services with AACP Director of
Communications Rebecca M. Morgan at the Exhibitor’s
Opening Reception.
Bottom: Jimmy R. Mitchell (middle), former director of
the Office of Pharmacy Affairs at the Health Resources
and Services Administration, accepts the AACP Distinguished Service Award at the Closing Banquet with Immediate Past President Dr. Jeffrey N. Baldwin (left) and
AACP Executive Vice President and CEO Dr. Lucinda L.
Maine (right).
his office administers the 340B Drug Pricing
Program through which more than 14,000
outpatient clinics and disproportionate share
hospitals purchase approximately $5 billion annually in discounted drugs. Mitchell accepted the award with “great awe” and
thanked his family and rewarding relationship
with AACP. He also thanked his two sons,
whose surprise attendance at the banquet
brought tears to Mitchell’s eyes as they read a
note from his wife who was unable to attend.
Dr. Victor A. Yanchick, AACP past president, was presented with a presidential
clock honoring his continued service to the
Association and the Academy. Following the
presentation, he led the audience in a rousing sing-a-long to Janis Joplin’s “Mercedes
Benz.” Dr. Frank S. Abbott, retiring director
of the Association of Faculty of Pharmacy
of Canada and the Association of Pharmacy
Deans of Canada, was also recognized at the
banquet for his commitment and support
of pharmacy education in North America.
Abbott was instrumental in the success of
the AACP/AFPC joint meeting in 2008 in
Chicago and in the founding of the Global
Alliance for Pharmacy Education.
AACP would like to gratefully acknowledge the generous support of the meeting’s
sponsors and exhibitors, as well as the many
speakers and contributors who helped make
the 2010 Annual Meeting an unequivocal
success. While the bar has been raised yet
again for the 2011 Annual Meeting July
9–13 in San Antonio, AACP will continue
to build Bridges to Our Bright Future in pharmacy education and practice through the
Annual and other AACP meetings. We hope
to see you there!
President Carter Believes Pharmacy’s Stars Are Aligning
AACP President Dr. Rodney A. Carter, associate dean and professor at the
University of Minnesota College of Pharmacy, announced that during his
presidential term he’ll focus on expanding innovative models of pharmacy
practice. President Carter believes pharmacy’s stars are aligning to provide
new opportunities in compensation for pharmacy services; fellow health
professionals and the medical home models are recognizing pharmacists’
value in the healthcare team; pharmacist-provided primary care is gaining
support; and the knowledge and evidence generated by academic pharmacy has opened many doors in healthcare reform legislation.
To learn more about President Carter’s vision of “The Stars Are
Aligning,” visit the AACP Annual Meeting Web site at www.aacp.org
/annualmeeting10. —Maureen O. Thielemans
21
Leading by
Example
Creating the next generation of leaders
in pharmacy among our students and faculty
is a top priority for colleges and schools across
the country. Whether through elective courses, special
retreats and institutes, or earmarked funding to aide students
in attending professional meetings, leadership development models
are being utilized throughout the Academy. Academic Pharmacy Now takes a
look at how some schools are working to ensure that the profession of pharmacy
has adequate numbers of change agents for the future.
Midwestern University/Downers Grove
Midwestern University’s Chicago College of Pharmacy sponsored a Student Leadership Institute for the last several years,
offering innovative skill-building exercises and opportunities
to not only its own students, but also to students from neighboring pharmacy colleges.
and then communicate independently throughout the duration
of the program. Encompassed within the program is the opportunity for the student to shadow his or her mentor during a
leadership activity such as attending an association committee
or board meeting, or a meeting at the mentor’s practice site.
The biannual program is open to all second- and third-year
student pharmacists throughout Illinois who are chosen
through a competitive process. Selected students commit to
attend four educational sessions spread over a four-month
period. In addition to providing innovative leadership skilltraining offered by professional training organizations, the
Institute pairs each student with a pharmacy mentor who is already established in a pharmacy career. The student and his or
her mentor meet to discuss the goals and expectations of each,
Some of the topics offered at past Institutes include communication, awareness of self and others, situational leadership
and business etiquette. Another requirement of the Institute is
to have the student present a “Careers in Pharmacy” talk at a
local high school. This provides the student an opportunity to
practice the skills he or she has learned in the course, to model
leadership traits for others and to perhaps attract leaders of the
future to the profession.
22
University of Illinois at Chicago
This fall, the new University of Illinois at Chicago
College of Pharmacy at Rockford opens its doors to
its inaugural class. The establishment of this regional
campus is the result of efforts spearheaded by Dean
Jerry Bauman to expand the institution’s presence as the
flagship college of pharmacy within the state of Illinois.
An exciting piece of the Rockford curriculum will be
the Rural Pharmacy Education Program (RPharm)—
modeled after the highly successful Rural Medical
Medication Program (RMED) run by the University of
Illinois College of Medicine at Rockford. This program
recruits students from rural, medically underserved
areas of Illinois and trains them in the unique aspects of
rural healthcare in hopes that they will become primary
care physicians practicing in rural areas of Illinois upon
completion of their training.
The RMED Program has been highly successful, with
80 percent of students going into primary care and 70
percent practicing in rural Illinois. The College of Pharmacy plans to use the same recruitment methods and
curriculum as RMED. RPharm students will train interprofessionally with medical students during their four
years at Rockford with the hope that they will develop
collaborative practices in rural areas upon graduation.
This program has the potential to develop a unique
practice model that can significantly improve healthcare
delivery in rural communities.
In an effort to facilitate the development of pharmacists who will
seek to lead change, the University of Minnesota College of Pharmacy offers a focused set of intentional learning opportunities that
build on one another and reinforce one another.
The college’s Leadership Emphasis Area (LEA) within the
Pharm.D. curriculum allows students to engage in multiple didactic, experiential and self-directed learning activities. In 2010, nine
students graduated with the Leadership Emphasis and 13 students
graduated in 2009. Fifteen students from the Class of 2011 are
currently enrolled in the program.
Student pharmacists can start taking leadership elective courses
during their second or third professional year that focus on core
attributes of successful leaders and the strategies used to lead
change. For those who choose to continue in the LEA, the experience extends throughout their fourth year and encompasses a total
of 18 credits.
Students who have participated in the school’s leadership development courses have highlighted the Leadership Networking
Partners (LNP) program as one of their most valued experiences.
The program pairs students with recognized pharmacist leaders
from the Minnesota community for a longitudinal shared mentorship experience. Students are assigned a pharmacist with whom
they will meet at least four times over the course of a semester via
two one-on-one, off-campus visits and two campus-based group
sessions. This program is embedded in two 2-credit courses titled
Leading Change in Pharmacy.
After completing the Leading Change in Pharmacy courses,
students can elect to continue in the Leadership Emphasis Area.
Among other requirements, students enrolled in the LEA are
required to enroll in an experience titled Leading Change Project,
which engages students in identifying an area in which change
is needed, develop a vision for change and apply the principles
learned from previous coursework while leading the desired change.
Above: Kassandra Bartelme, a 2009 LEA graduate, said
“Through the LEA, I learned valuable information about leading
change, project management and the importance of networking—all of which is not taught in traditional courses. The LEA
gave me opportunities I would not have had otherwise—opportunities that opened my eyes to the impact even one pharmacist can have on the profession.”
Left: Graduates of the 2010 Leadership Emphasis Area program
are: (back row) Michael Schroeder, Ilya Danelich, Arinzechukwu
Nkemdirim Okere, Stacey Rewitzer and (front row) Ashley Gray,
Alexia Knick, Dianna Seng, Meghan Kelly and Alison Knutson.
23
University at Buffalo, The State
University of New York
Faculty at the University at Buffalo, The State University of New York (UB) were
growing concerned that a potential critical leadership shortage within the profession
of pharmacy could occur if students are not able to access the skills and guidance
necessary to develop strong leadership capabilities.
South Carolina College
of Pharmacy
At the South Carolina College of Pharmacy
(SCCP), leadership development is a central
tenet of a quality improvement initiative
called SCCP Excellence. The program is
designed to hardwire behaviors that enable
the college to reach organizational goals
through measurable and accountable individual action. The tools to implement SCCP
Excellence help current leaders with mentoring and assessing, help future leaders to
develop, and help both reach their goals.
“SCCP Excellence is all about aligning department goals with college goals and then
raising everybody’s level of leadership and
accountability,” said Dr. Joseph T. DiPiro,
executive dean. “We all have an individual
responsibility for reaching the goals we set
collectively. SCCP Excellence gives us the
process for systemic quality improvement
through behavior modification, leadership
development, and rigorous assessment.
Without strong leadership, the other two
don’t happen.”
Examples of leadership development models at SCCP include Leadership Development Institutes; leaders “rounding” with
their employees regularly to find out what
systems are working well, what tools they
could use to do their jobs better and who
should be recognized for exemplary work;
and assessment, wherein the college utilizes
Key Performance Indicators that offer
benchmarking and metric-based assessment.
“The overall model of SCCP Excellence is
for institutional quality improvement,” said
DiPiro. “But leadership development is an
integral part of how you get there.”
24
To address this concern, Dr. William A. Prescott Jr., clinical assistant professor, and
Dr. Gayle A. Brazeau, former associate dean for academic affairs, began organizing a
leadership elective allowing Pharm.D. students the opportunity to enhance their leadership potential. In 2008, the UB School of Pharmacy and Pharmaceutical Sciences
designed Developing Leaders in Pharmacy, a one-credit hour, two-semester elective
course to introduce students to leadership in the profession of pharmacy. Enrollment
in this course is limited to 12 second- and third-professional year students. Given the
limited number of available seats, students must formally apply to the course, with
preference given to students who have held and currently hold leadership positions,
as these students have the opportunity to reflect upon previous and current experience as leaders. The primary goals of this course are to provide students with the
tools necessary to develop their leadership skills and to encourage them to continue
developing these skills upon completion of the course.
Students are assigned readings on topics such as identification of personal strengths
and weaknesses, communication skills, relationship building, attitude, professionalism and ethics. Classroom discussions are student-led and are facilitated by the
course coordinator and guest speakers who exemplify the attributes of a leader.
To assess the impact of this course on participating students, an anonymous online
survey was distributed, with student responses being very positive as to the impact of
the course; 95 percent agreed or strongly agreed that this course prepared them to be
a more effective leader, with 90 percent indicating that they plan to continue developing their leadership skills beyond graduation from the course.
Albany College of Pharmacy and
Health Sciences
The Albany College of Pharmacy and Health Sciences (ACPHS) Leadership and Professional Development Fund was established nearly 10 years ago by President James
J. Gozzo to help students develop professional and leadership skills, represent the
college at key conferences and meetings, and bring new skills and knowledge back to
the ACPHS community. The fund is chiefly designed to cover the cost of registration
fees for professional conferences and symposia.
In the past four academic years alone, the college has provided financial support
of nearly $45,000 to help approximately 300 students attend such events. Students
approved for funding have used the money to attend meetings and events of organizations such as the American Pharmacists Association–Academy of Student Pharmacists, American Society of Health-System Pharmacists, Infectious Disease Society of
America, American College of Clinical Pharmacy, College of Psychiatric and Neurologic Pharmacists and the American Society of Consultant Pharmacists.
To ensure a wider segment of the campus benefits from each granting of funds,
conference attendees are required to complete an educational activity related to their
conference experience within 30 days of attending an event. Examples of educational
activities include writing an article for the student newspaper or conducting an oncampus informational session.
The Leadership and Development Fund has seen increased interest in recent years
and the college expects annual requests to surpass $15,000 in the near future.
feature story
The University of Toledo College of Pharmacy is developing leaders in the field of medication
therapy management (MTM), in a way that few other schools have done, through a course
titled Medication Therapy and Disease State Management. This course, a requirement for the
Pharm.D. curriculum since spring of 2005, is remarkable in its scope and focus on medication
therapy management.
Above: The University of Toledo
College of Pharmacy held its first
annual leadership retreat at Camp
Miakonda, a local camp that hosts a
Leadership Challenge Adult Leadership Development Program. The
camp has an outdoor course that
challenges participants to work together to conquer difficulties and
solve problems while positively
encouraging one another.
The cutting-edge course covers not only the clinical side of MTM, but also the development,
implementation and evaluation of these programs in real-life settings. The programs developed
in the course are not just hypothetical. Each year, about 30 percent of the programs developed
by students in this course are actually implemented by the pharmacists with whom they work.
In fact, the Lucas County Medication Therapy Management program that is in its fifth year is
an expansion of a program developed by students in the course. This program has been able to
demonstrate and sustain key outcomes, generating interest from other employers in the area who
are interested in starting and sponsoring pharmacist-provided MTM programs for their own employees. By developing these MTM programs, students at The University of Toledo gain valuable
experience that contributes to improved health outcomes in their communities.
In addition to its MTM leadership course, the college held its first annual leadership retreat for
the officers of all 11 student pharmacist organizations and select incoming freshmen. The student participants spent a day in workshops and team-building activities designed to forge bonds
between the groups and allow them to get to know one another. Students participated in an
outdoor challenge at Camp Miakonda, then listened to a presentation on “authentic leadership”
delivered by a member of the Department of Management faculty. The daylong retreat culminated with a Student Leadership Dinner sponsored by Walgreens.
25
feature story
Academic
Pharmacy
Advances
Science While
Stimulating the
Economy
On Feb. 13, 2009, Congress passed the American Recovery and Reinvestment Act of 2009 (ARRA) to spur domestic job creation in emerging
industries and create a long-term foundation for economic growth. As
part of the overall $100 billion federal government investment, funding
was provided to federal public health agencies including the National
Institutes of Health (NIH), the Centers for Disease Control and Prevention and the Health Resources and Services Administration (HRSA). This
edition of Academic Pharmacy Now highlights colleges and schools of
pharmacy across the country that are utilizing these funds to advance
science, improve health, and stimulate innovation and economic growth.
27
feature story
Purdue University
Dr. Eric L. Barker, assistant dean for graduate programs and
associate professor of medicinal chemistry and molecular
pharmacology, received ARRA funding to support the development of cutting-edge techniques to allow the characterization of chemicals involved in brain signaling, which are
derived from fatty acids. These molecules, endogenous cannabinoids, mimic the actions of marijuana in the brain. They
are involved in multiple physiological processes including
controlling pain, stress response, appetite and mood. By
measuring these compounds in the brain with this new technology, it may be possible to identify new pathways that can
be targeted with new therapeutic drugs.
Understanding the molecular basis for controlling the production and metabolism of the endogenous cannabinoids is
critical for future therapeutic drug discovery efforts targeting
this system. Such drugs have potential therapeutic effects in
conditions such as convulsions, movement disorders, epilepsy, chronic pain, anxiety, obesity, multiple sclerosis and
glaucoma.
Also receiving funding was Professor of Medicinal Chemistry Dr. Robert L. Geahlen, whose application funded through
the ARRA was for a “competitive revision” that sought support to extend the specific aims of a currently-funded proposal. The parent grant focused on an exploration of the role
certain protein molecules called protein kinases play in the
immune system.
28
The new research is attempting to apply results obtained
in studies at the cellular level
to an entire organism. The
goal is to help understand
the immune system of a
whole animal by developing a “knock-in” mouse in
which a gene that originates
from within an organism is
replaced by a gene that encodes an engineered form of
the enzyme.
Engineering a normal gene
for a protein involved in regulation of immune cells into
one that can be turned off
when desired will help reveal how lymphocytes recognize pathogens and how
cells respond to a foreign
pathogen by becoming activated to produce antibodies
to that particular pathogen.
The results of this research
could provide a platform for
further understanding the
development and activation
of immune cells.
feature story
Through the ARRA, the NIH has awarded a competitive grant
of more than $777,000 to University of Maryland School of
Pharmacy and Johns Hopkins University researchers to
study the costs, risks and benefits of treatments for blood
disorders that affect more than 10,000 elderly patients each
year.
The challenge grant targets a widely accepted practice by clinicians of controlling anemia of myelodysplastic syndromes
(MDS), sometimes called pre-leukemias, with erythropoietin,
a hormone controlling red blood cell production.
Drugs called erythropoietin stimulating agents, or ESAs, are
effective in treating anemia in MDS patients. However, little
is known about the drugs’ longer-term health effects. Myelodysplastic syndromes are the most common hematologic
malignancy in the elderly.
“In this study, we will use data from regional cancer registries
that are linked to Medicare enrollment and insurance claims
data,” said Dr. Amy J. Davidoff, research associate professor of pharmaceutical health services research (PSHR) at the
School of Pharmacy. “We will examine the characteristics
of Medicare beneficiaries with MDS, patterns of treatment,
safety and effectiveness of ESA use, and costs of care.”
University of
Maryland
Doctors have treated MDS
patients with ESAs to control anemia for about 15
years. This treatment has
had a 20 to 40 percent response rate and median
response duration of two
years. However, there is a
serious lack of large-scale
clinical trial evidence supporting longer-term clinical benefits, according to
Davidoff and co-grantees,
Dr. Sheila Weiss Smith,
a professor in PHSR and
director of the School of
Pharmacy’s Center for
Drug Safety, Dr. Maria
Baer, professor and director of the Hematologic
Malignancies Program at
the University of Maryland Marlene and Stewart
Greenebaum Cancer Center, and Dr. Steven Gore,
professor at Hopkins Sidney Kimmel Comprehensive Cancer Center.
29
feature story
The University of
Mississippi
The University of Mississippi (UM) has received $31.7
million to expand the Thad Cochran Research Center,
the primary research facility of the School of Pharmacy’s National Center for Natural Products Research
(NCNPR).
“It is exciting to see the achievement of this milestone
for Ole Miss and the School of Pharmacy,” said Dr.
Larry A. Walker, NCNPR’s director since 2001. “This is
another major step toward a world-class natural products research center, as envisioned by the school’s
leaders over two decades ago.”
HRSA and the U.S. Food and Drug Administration are
providing $17.8 million and the NIH is providing $13.9
million.
Competition for the NIH funds was stiff, as each qualifying institution was allowed to submit up to three proposals to its Extramural Research Facilities Improvement Program. Under this program to renovate or
construct facilities supporting biomedical or behavioral research, NIH made 63 awards totaling $675 million.
UM’s pharmacy school is the only Mississippi recipient
and the nation’s only pharmacy school to receive an
award from this program.
Designed for research involving discovery of natural
products for pharmaceutical and agricultural commercialization, construction of NCNPR’s first phase began
in 1992 with USDA funds appropriated by Congress.
Personnel occupied the partially completed facility in
1995, and this 115,000-square-foot building was completed in 2000.
The second building will complete the NCNPR complex
and enable researchers to translate basic research
into clinical studies and commercial natural products.
Its amenities will include a facility for clinical studies,
30
an expanded specimen repository and laboratories for
scaling-up extraction and synthesis of bulk natural products,
determining a natural product’s toxicity and mechanism
of action at the cellular level,
and discovering microbial and
marine natural products.
“Completion of the center envisioned so long ago is finally within our grasp,” said Dr.
Barbara G. Wells, dean of the
School of Pharmacy. “This second research building will allow us to advance our research
programs to the next level.”
feature story
University of Houston College of Pharmacy researchers received a total of $1.47 million in new or
supplemental research awards from the NIH through the ARRA.
Dr. Richard A. Bond, professor of pharmacology, received a two-year, $682,000 grant from the National Institute of Allergy and Infectious Diseases for the next phase of his ongoing investigation into
the use of beta2-adrenoreceptor (ß2AR) inverse agonists as a potential therapeutic agent for mild,
chronic asthma.
Through Bond’s previous research and in two related small-scale clinical trials, chronic administration of beta blockers decreased airway hyper-responsiveness and produced broad anti-inflammatory
effects, including dramatic changes in airway epithelium and reduced mucous production. The new
R01 grant for “Mechanisms of beta-blocker induced improvements in asthma” will test Bond’s hypothesis that beta-blockers influence airway epithelium via ß2ARs to exert their therapeutic effects.
Dr. Ke-He Ruan, professor of pharmacology and director of the college’s
Center for Experimental Therapeutics and Pharmacoinformatics, has received a two-year, $450,000 award
from the NIH’s new Challenge Grants
in Health and Science Research (RC1)
program for “Prostacyclin-secreting
Cells as Therapy for Pulmonary Artery
Hypertension.”
Ruan serves as a principal investigator with another principal investigator,
Dr. Richard Dixon, director of the Wafic
Said Molecular Cardiology Research
Lab in the Texas Heart Institute at St.
Luke’s Episcopal Hospital. Their work
is based on Ruan’s pending U.S. patent for a novel, engineered “tri-catalytic” enzyme that produces a vascular
protector against heart disease called
prostacyclin, which dilates blood vessels and prevents blood clots. Prostacyclin is reduced in patients with pulmonary arterial hypertension, which
is a rare, but incurable disease with a
high mortality rate. The National Heart,
Lung and Blood Institute’s total twoyear award for the collaborative project
is $1 million.
projects, which supported the addition of a Houston-area high school science teacher to his lab in the summer of
2009.
Assistant Professor of Pharmaceutics
Dr. Romi Ghose received a one-year,
$53,954 supplement from the National
Institute of Diabetes and Digestive and
Kidney Diseases for her K01 study of
“Hepatic Drug Metabolism in Inflammation.” Ghose is investigating the mechanisms by which expression of key drug
metabolizing enzymes is suppressed in
the liver during inflammation and infection, which increases susceptibility to
adverse drug reactions.
Also receiving ARRA funding is Dr. Bradley K. McConnell, assistant professor of
pharmacology. His two-year, $260,876
supplement from the National Heart,
Lung and Blood Institute will help further
his investigation into whether disruption
of a cardiac molecular signaling pathway
that affects contractility may yield a new
therapeutic target for patients with heart
failure. The supplement supports a new
post-doctoral fellow, as well as lab equipment and supplies, for the next phase of
his R01 grant on “Targeted Disruption of
Ruan also received a $24,696 suppleBeta-adrenergic Signaling to Increase
ment to his existing NIH-funded R01
Cardiac Contractility.”
31
feature story
32
feature Improving the quality and coordination
ofstory
care
for patients through a physician-led, integrated team approach is the foundation for the
Patient-Centered Medical Home (PCMH) model.
There’s
No Place
Like the
Medical
Home
33
feature story
While not a new concept, the PCMH has been the topic of recent discussion, due in large part to the Patient Protection and Affordable
Care Act of 2010 (PPACA). The act includes provisions that authorize
the development, implementation and evaluation of PCMH models,
which will provide health professions educators with numerous opportunities to play a significant role in the medical home discussion.
Some pharmacy faculty at our nation’s colleges and schools
of pharmacy are already leading the way in promoting
the role of the pharmacist and health professions educator in the PCMH model of care. University of Connecticut
pharmacy faculty member Dr. Marie A. Smith’s article asserting “Why Pharmacists Belong in the Medical Home”
in the May 2010 edition of Health Affairs illustrates the
effect pharmacists can have in the delivery of primary
care through effective medication therapy management.
As well-educated and highly-skilled health professionals,
pharmacists can utilize their complementary knowledge
to provide better care for patients, she said, however;
they are often underused in the medical home model.
Other members of the Academy are becoming engaged
in the medical home discussion, as evidenced in this
edition of Academic Pharmacy Now. Whether helping
patients understand the
complexity of their medication regimen or providing
care to the underserved at
a federally-funded health
center, America’s pharmacy educators are undoubtedly improving the quality
and coordination of care
through the Patient-Centered Medical Home.
34
feature story
In early 2009, the University of Pittsburgh School of Pharmacy,
University of Pittsburgh Medical Center (UPMC) St. Margaret and
the UPMC Health Plan partnered to attempt to answer the question:
How can the pharmacist provision of care be economically viable and
available to greater numbers of patients in order to improve care? This
question is the basis for the “Successful Collaborative Relationships
to Improve PatienT care (SCRIPT) Project,” which aims to integrate
pharmacists into a medical home.
The foundation of the SCRIPT Project is the unique perspective and
collaboration of each of the partners. UPMC St. Margaret is a 249bed acute care hospital with more than 800 associated primary care
and specialty physicians. Their researchers include a physician leader,
pharmacist leader, pharmacy resident and hospital administrator who
all bring an interest in the medical home model, improving patient
care and supporting physicians in their practices. The UPMC Health
Plan is a full-range health insurance provider whose researchers
include pharmacist leaders, a health economist and a research project
leader. The School of Pharmacy research team includes pharmacist
faculty and a community pharmacy resident who are interested in
understanding how a pharmacist can successfully integrate into a
medical home and, in turn, how to make that integration replicable,
scalable and sustainable. The University of Pittsburgh School of Medicine Department of Family Medicine researchers include two physician faculty members who serve as advisors to the project.
Together, this diverse research team seeks to carry out the project’s
goal of identifying the impact of a pharmacist providing care and
service in family practice/medical home offices.
The project involves two pharmacists who have been integrated halftime into four family physician office practices each operating as a
medical home. Each pharmacist is responsible for two family physician practices. The pharmacists provide direct, individualized patient
care, provide medication reconciliation upon hospital discharge, and
contribute to overall medication-related management of the practice
(diabetes education, anticoagulation protocols, etc). The pharmacists document their patient care encounters in the electronic medical
record and study databases. They meet regularly with a member of the
research team to review patient cases and ensure consistency of care
between sites. In addition, the research team meets on a routine basis
to review the overall progress of the project and keep to the agreed
upon timeline.
The partnership has been essential for the School of Pharmacy’s success at being willing to “look outside of the (academic) box” and see
opportunities for collaboration. Whatever the outcome of the SCRIPT
Project, the School of Pharmacy will have learned vital information
as to the role of the pharmacist in the medical home, the impact on patient care and the physician practice, and the appropriate education of
pharmacists, physicians and others to create an ideal functioning team
in the medical home.
35
Two University of Connecticut (UConn) School of Pharmacy faculty
members, Dr. Stefanie C. Nigro, assistant professor of pharmacy practice, and Dr. Fei Wang, associate clinical professor of pharmacy practice, have been working toward increasing the role of the pharmacist in
the medical home through their work in Connecticut medical facilities,
in addition to educating students about such an important role.
Nigro works at a federally-funded health center in Connecticut that
primarily serves patients who are underserved, underprivileged, and
in most cases, lacking adequate insurance. She works with the other
physicians and nurses, taking an active role in the medical home
model. For her, the medical home is “a fundamental way of thinking
about coordinating continuous care for patients when they come to
see their physicians.”
Nigro currently has two UConn students working with her. In order
to teach them more about patient care, the students accompany her
to patient visits and assist in medication reconciliations. The students
compile medication history and help with educating the patients,
such as teaching them how to use blood pressure meters, insulin pens,
inhalers, etc.
Wang works at Hartford Hospital in a primary care teaching clinic
that is affiliated with the UConn Schools of Medicine, Pharmacy, and
Nursing. Like Nigro, she provides her pharmacy services as part of a
team-based model of care to a culturally diverse, medically challenging and mostly underinsured and underserved population of Hartford.
Wang is responsible for the development and implementation of new
collaborative practice pharmacy services in the adult primary care
practice. She developed a smoking cessation program and a cardiovascular risk reduction program in the areas of diabetes mellitus, hypertension and hyperlipidemia to emphasize wellness and prevention
strategies in primary care. Patients are referred by their primary care
providers to the pharmacy service for collaborative care management,
medication therapy management or patient education. These programs are a great complement to current physician and nursing staff
services and provide another level of more individualized patient care,
which motivates and empowers patients to self-manage their chronic
disease states better.
As a member of the primary care interprofessional team to improve
medication use and enhance patient safety, she works closely on a
daily basis with providers in their continuity of care clinics to improve
medication reconciliation, interview patients for a medication history, identify drug-related problems, identify non-compliant patients,
recommend appropriate evidence-based interventions, provide patient
counseling and education, and help monitor patient outcomes. Her
student pharmacists are integrated into this medical model and enjoy
the close interprofessional collaboration with UConn medical students, medical residents and staff.
36
Duquesne University
Student pharmacists from Duquesne University sit in utter disbelief
with a patient who proceeds to dump no less than 50 prescription
bottles onto the consultation table at the pharmacist’s clinic office. A
physician-assistant student also sits in on the consult. This is where
a clinical pharmacist spends time with experiential students at an
Advanced Pharmacy Practice Experience (APPE) site in an unofficial
medical home.
The clinic is housed within a primary care medical practice located in
downtown Pittsburgh about six blocks from campus. The patient is
one of nearly 200 who have been referred to Dr. Hildegarde J. Berdine,
associate professor of pharmacy practice, by the primary care physicians over the past two-and-a-half years for a variety of consultations.
The patient has congestive heart failure and is overwhelmed by all the
prescription medicine he receives through his mail order plan.
Many of the pharmacist-patient interactions are centered on medication adherence as was evident in the scene just described. Other
consultations involve disease management for diabetes, obesity or
congestive heart failure. Following up on specific drug therapy, averting adverse drug problems and optimizing therapy are important facets of care offered to patients of this medical home practice. Patients
have developed strong relationships with Berdine and continue to see
her for support in diabetes self management, weight reduction and
pre-bariatric surgery counseling and pain management. Some patients
bring medication trays to be filled by Berdine and her students with
their own prescription medicines, samples, or medicines secured by
Prescription Assistance Programs. A number of these patients have
fallen on hard times, becoming unemployed or working in low paying
jobs without health insurance.
Berdine and her students ensure that all diabetes patients who consult
with the pharmacist are assessed at each visit for compliance with performance measures indicated on a standard flow sheet from various
health insurance plans. Clinical pharmacists support health information technology by teaching staff and physicians how to use electronic
medical records, e-prescribing software, evidence-based medicine
treatment algorithm tools and other clinical decision support tools.
Pharmacists are a readily-available drug information source within
the medical home. The physicians ask Berdine for evidence to support their clinical decisions. The clinical pharmacist documents the
patient visit in standard SOAP format including an updated problem
list, medication list and patient-oriented goals. Berdine insists that the
medication list is up to date and accurate, a sometimes difficult task in
the outpatient setting. Medication reconciliation is conducted at each
visit and most importantly during the first week of discharge from the
hospital when the patient follows up with his/her physician. Berdine
supports the patient by teaching self management skills and empowers
the individual to take control of their chronic disease. She enlists the
patient’s input in developing a care plan and clear achievable goals.
Motivational interviewing skills and identification of stages of change
are used to facilitate patient progress.
37
Target Your Advertising
Dollars with Us!
How can you advertise to every college and school of pharmacy in the nation?
Through Academic Pharmacy Now!
Reach more than 4,000 pharmacy educators through our new quarterly publication.
Launched in February 2008, Academic Pharmacy Now can help you target your advertising to the most important group of people in future pharmacists’ lives: their
educators and mentors.
2010 Classified Ad Rates
Classified Advertising Rates
(per insertion)
Full Page
Corporate
and
Institutional
Members
Non-members
1 time
$2,600
$3,200
2 times
$2,160
$2,840
4 times
$1,720
$2,480
Corporate
and
Institutional
Members
Non-members
½ Page
1 time
$1,500
$2,700
2 times
$1,160
$2,260
4 times
$820
$1,820
38
Call us today to discuss
how your company
can take advantage of
this invaluable advertising opportunity in
the most widely read
pharmacy education
magazine available!
Contact
Rebecca Morgan at
703-739-2330 x1032
or [email protected].
faculty news
Faculty News
Auburn University
Drake University
Appointments/Elections
• Jessica Ballone, assistant clinical professor of pharmacy practice
• Brian Gentry, assistant professor of pharmacology
• Richard Hansen, professor and department head of
pharmacy care systems
• Sherry P. Martin, assistant clinical professor of
pharmacy practice and director of the Introductory
Pharmacy Practice Experience program
• David J. Riese II, associate dean for research and
graduate programs, and professor of pharmacal sciences
• Xiaoyi Shan, assistant professor of health sciences
Awards
• Renae J. Chesnut received the C. Boyd Granberg
Professional Leadership Award.
• Sheryl L. Compton received the Faculty Preceptor of
the Year Award.
• Michele Evink received the Adjunct Faculty Preceptor of the Year Award.
• Pamela L. Stamm has been named to the editorial
board of Diabetes Spectrum.
• Megan Friedrich received the Hartig Faculty Development Award.
Grants
• Sarah E. Grady received the Teacher of the Year
Award.
• Heather P. Whitley is principal investigator for a
grant, Walking in Diabetic Shoes, funded for 20102013 at $2,500 by Medical Scholars Week.
• William R. Willard, Family Practice and Medical
Student Endowed Support Fund; the University of
Alabama School of Medicine, promotes educational
excellence for students and supports priority needs
in the College of Community Health Sciences at the
University of Alabama.
Promotions
• Salisa Westrick was promoted to associate professor
with tenure.
Retirements
• Robert E. Smith, professor of pharmacy practice is
retiring, effective Sept. 1, 2010.
• Melissa M. Murer Corrigan received the 2009 Lawrence C. and Delores M. Weaver Medal of Honor.
• Melissa Nelson received the Introductory Practice
Experience Preceptor of the Year Award.
• Charles R. Phillips was recognized with an Award for
Excellence in Assessment from AACP.
• Denise A. Soltis received the Hartig Distinguished
Professor Award.
• Geoffrey C. Wall received the Mentor of the Year
Award.
Promotions
• June F. Johnson has received a promotion to the
rank of full professor of pharmacy practice.
• Kristin S. Meyer has received a promotion to the
rank of associate professor.
• Craige C. Wrenn has received academic tenure and a
promotion to the rank of associate professor.
39
faculty news
Duquesne University
Grants
• Jelena M. Janjic, principal investigator. Project Title:
Perfluorocarbon Nanoemulsions for Simultaneous
Delivery of COX2 Inhibitor and Antiproliferative
Agent to Breast Tumors. Period of Project: June 1,
2010 to May 30, 2012. Source: Duquesne University
Faculty Development Fund (FDF). Amount Granted
09-10: $9,968. Total Grant: $9,968.
• David A. Johnson, principal investigator. Project
Title: Effect of Caffeine and Choline on Short-term
Memory in Adult and Middle Aged Human Subjects.
Period of Project: April 30, 2010 to May 1, 2011.
Source: Interdisciplinary Research Program of the
Mylan School of Pharmacy and Graduate School of
Pharmaceutical Sciences. Amount Granted 09–10:
$3,800. Total Grant: $3,800.
• Khalid Kamal, principal investigator. Project Title:
Examining the Consequences of Multiple Sclerosis
from a Patient Perspective. Period of Project: April
1, 2010 to Aug. 30, 2010. Source: Novartis Pharmaceuticals Corporation. Amount Granted 09–10:
$20,268.75. Total Grant: $20,268.75.
• Jamie L. Kearns, principal investigator. Co-Investigators: Robert L. Maher Jr., Autumn Tami. Project
Title: Community Pharmacist Clinical Intervention.
Period of Project: March 1, 2010–March 1, 2011.
Source: Pennsylvania Pharmacists Association
(PPA) Educational Foundation. Amount Granted
09-10: $500. Total Grant: $1,000.
Promotions
• Peter L. Wildfong, associate professor
East Tennessee State University
• L. Brian Cross, associate professor and vice-chair of
pharmacy practice
• Michael A. Crouch, professor and associate dean for
professional education and academic affairs
• Stacy E. Eon, assistant professor of pharmacy practice
40
Lake Erie College of
Osteopathic Medicine
• Kimberly A. Burns was recently inducted as president of the American Society of Pharmacy Law.
Awards
• Hershey S. Bell was presented with the American
Association of Colleges of Osteopathic Medicine
William D. Miller Award.
Mercer University
Grants
• Ashish A. Advani and Jessica L. Jones, fourth-year
student pharmacist, were awarded a $6,000 grant
from Community Pharmacy Foundation for “The
role of picture-based patient education pamphlets
for enhancement of patient comprehension of prescription medication information.”
• Ajay K. Banga received a grant of $60,000 for “Investigate strategies to increase and measure dermal
levels of cosmeceuticals” from Skin Medica Inc. He
was also awarded a $17,500 grant from Skin Medica
Inc. to investigate “enhancement strategies for delivery of cosmeceuticals.”
• Vanthida Huang, J.P. Salomone, P. Abraham, et al.
received a grant in the amount of $68,000 to coinvestigate “Pharmacokinetic and pharmacodynamic
evaluation of doripenem in critically ill trauma
patients with sepsis at Grady Health System” from
Ortho-McNeil Pharmaceutical, Inc.
• Nader H. Moniri received a grant of $15,000 for “In
vivo analysis of the role of omega-3 fatty acids in
regulation of GPR120 expression” from the Diabetes
Action Research Foundation.
• Michelle B. Redding received a grant of $14,300
for “Developing a pediatric medication treatment
management program” from Community Pharmacy
Foundation.
• Chad M. VanDenBerg was awarded a grant for
$63,350 from Solvay Pharmaceuticals for Solvay/
Mercer Fellowship in Clinical Drug Development.
ion:
Caut s at
ber
Mem rk
Wo
feature story
Members Working For
You
Pharmacists on Healthcare Teams
Significantly Improve Patient Care
Incorporating pharmacists as members of the healthcare team
in direct patient care roles is a viable solution to improving U.S.
healthcare, according to the results of a comprehensive, systematic review of the healthcare literature led by AACP member Dr.
Marie A. Chisholm-Burns.
The article, “US Pharmacists’ Effect as Team Members on Patient
Care: Systematic Review and Meta-Analyses,” is set to be published in the October 2010 edition of Medical Care and examines
the effect of pharmacist-provided direct patient care on therapeutic, safety and humanistic outcomes. Dr. Chisholm-Burns, University
of Arizona College of Pharmacy department head and professor
of pharmacy practice, led a team of researchers who found that
involving pharmacists in direct patient care activities has favorable
effects, including reducing adverse drug events and improving
outcomes for patients with chronic diseases.
The interprofessional team comprised of experts in pharmacy,
medicine, nursing, health economics, public health, library science,
social work and information technology conducted a search that
led them to more than 50,000 articles, which was narrowed down
to approximately 300 that met study criteria for the systematic
review.
“We’re trying to help determine the effectiveness of pharmacists
who are providing direct patient care,” Chisholm-Burns said. “Our
study is very comprehensive; it crosses age groups, practice environments and disease states.”
• Chad M. VanDenBerg and Alan C. Wright received
a grant in the amount of $21,216 for “Changes in
the pupillary light reflex in response to ingestion
of immediate-release and extended-release caffeine formulations” from The Beverage Institute
for Health and Wellness, LLC; and were awarded a
$15,252 grant from Eli Lilly and Co. for “Changes in
the pupillary light reflex in response to duloxetine.”
Retirements
• Richard A. Jackson, professor
Samford University
• Michael D. Hogue was elected president-elect of
American Pharmacist’s Association Academy of
Pharmacy Practice and Management.
• Anna Meador was appointed as pharmacy director
Study results revealed that patients were 47 percent less likely
to experience an adverse drug event when a pharmacist was
involved in their care. Pharmacist interventions also significantly
improved outcomes when pharmacists were involved in disease
management, particularly for patients with diabetes, hypertension
and dyslipidemia.
Communicating the study’s results to the public is a challenge, Chisholm-Burns added, but one that must be met to ensure patients
receive the best care possible.
“We are all consumers of healthcare and it’s important for Americans to understand how a pharmacist can help improve their care,”
she said. In her role as an educator, she instills in her students a
sense of responsibility and commitment to be excellent healthcare
providers through their words and actions. Inspiring leaders and
providing a forum through which they can build strong relationships and partnerships is also important.
Pharmacy educators like Chisholm-Burns all play a critical role in
working toward improving the public’s health, she said, and each
can provide a different piece of the puzzle.
“While the end-users, the patients, are closer to the pharmacy
practice faculty member, other pharmacy faculty all play a role. For
example, the medicinal chemist is making compounds that one day
they hope will be part of the solution to providing care. No one has
a larger contribution than the other, all of us are key stakeholders.”
of the Christ Health Center and assistant professor
of pharmacy practice.
Awards
• Susan P. Alverson, Pharmaceutical, Social and
Administrative Sciences Faculty Member of the Year
Award
• Jennifer W. Beall, Faculty Preceptor of the Year
Award
• Marshall E. Cates, Pharmacy Practice Faculty of the
Year Award
• Jeffrey A. Kyle, New Faculty Member of the Year
Award
• Elizabeth A. McCullough, Pharmacy Staff Member
of the Year Award
• Bruce Waldrop, Margaret Self Propst Pharmacy
Teacher of the Year Award
41
faculty news
Promotions
Retirements
• Kimberly W. Benner was promoted to professor of
pharmacy practice.
• Arnold W. Karig, campus dean for the Medical University of South Carolina
• Michael D. Hogue received tenure in the pharmacy
practice department.
Southwestern Oklahoma State
University
• David R. Luthin was promoted to associate professor
of pharmaceutical, social and administrative sciences.
• Angela Thomason was promoted with tenure to associate professor of pharmacy practice.
• Bruce Waldrop was promoted with tenure to associate professor of pharmaceutical, social and administrative sciences.
Pharmacy
• Charles Bennett, South Carolina Center of Economic Excellence Endowed chair in Medication Safety
and Efficacy and the Frank P. and Josie M. Fletcher
professor of pharmacy
• Kim Creek, vice-chair of the Department of Pharmaceutical and Biomedical Sciences
• Brie Dunn, assistant professor and clinical specialist
in critical care
Awards
• LeAnn B. Norris was named New Practitioner of
the Year by the Hematology-Oncology Pharmacists
Association.
Promotions
• Philip D. Hall, Medical University of South Carolina
campus dean
• Lorne J. Hofseth was promoted to associate professor with tenure.
• Heather Kokko was named permanent director of
pharmacy at the Medical University Hospital.
• Patrick D. Mauldin was granted tenure and promoted to professor.
42
• Jaehwa Choi, assistant professor
• Chelsea O. Church (president), Nancy Williams
(president-elect), Edna Patatanian (secretary) for
2010–11 were elected in the Oklahoma Society of
Health-System Pharmacists.
• Scott F. Long, chair, Department of Pharmaceutical
Sciences
• Hardeep Singh, assistant professor
Promotions
• Rahmat Talukder, associate professor of pharmaceutical sciences
• Nancy T. Williams, professor of pharmacy practice
University at Buffalo, The
State University of New York
• Alice C. Ceacarenu was appointed to the board of
directors of the New York State Council of HealthSystem Pharmacists Research and Education Foundation.
• Eugene D. Morse has been appointed at-large laboratory director to serve on the executive committee
of AIDS Clinical Trials Group. Morse was also appointed to the steering committee of the New York
State Research Centers Consortium.
• Robert G. Wahler has been named section leader of
the National Council of Hospice and Palliative Care
Professionals and will be part of the NCHPP Executive Committee.
faculty news
Awards
• Alice C. Ceacarenu was awarded the Clinical Pharmacy Services Research Award by the New York
State Council of Health-System Pharmacists for the
project “Evaluation the prognostic value of adiponectin levels in diabetics with breast cancer-role
of insulin sensitizers.”
• Alan Forrest received the Oncology One Award from
the American Society of Clinical Oncology.
Grants
• Alice C. Ceacarenu and Alan Forrest have been
awarded a $300,000.00 for the “Peter T. Rowley
Breast Cancer Research Grant” by the New York
State Department of Health.
Grants
• Amy C. Anderson, principal investigator. Source
of award: PHS/NIH/National Institute of General
Medicine Science. Amount of award: $263, 991.00.
Title: Design of C. Parvum and T. Gondii Dhfr-Ts
Inhibitors; and, source of award: National Institutes of Health/Duke University. Amount of award:
$3,200.00. Title: Computational Active-Site Redesign & Binding Prediction Via Molecular Ensambles.
• Brian J. Aneskievich, principal investigator. Source
of award: PHS/NIH/National Institute of Arthritis
and Musculoskeletal and Skin Diseases. Amount
of award: $272,298.00. Title: Keratinocyte Nuclear
Receptor Coactivators.
• William Baker, principal investigator. Source of
award: PHS/Agency for Healthcare Research and
Quality. Amount of award: $200,000.00. Title: Mechanical Thromboectomy in Acute Stroke.
• Urs A. Boelsterli, principal investigator. Source of
award: Pfizer, Inc. Amount of award: $159,600.00.
Title: Assessment of Drug-Induced Idiosyncratic
Hepatoxicity In Vivo Using the Heterozygous
Sod2+/- Mouse Model.
• Robin H. Bogner, principal investigator. Source of
award: FDA/National Institute for Pharmaceutical Technology and Education. Amount of award:
$66,000.00. Title: Scale-Up of Lyophilization Using
Dimensionless Prediction; source of award: U.S.
Pharmacopeia. Amount of award: $25,000.00. Title:
Establishing Best Practices in Dissolution Testing
for Drug Salts; source of award: PHS/FDA/National
Institute for Pharmaceutical Technology and Education. Amount of award: $9,294.00. Title: Development of Qbd Guidance Elements on Design Space
Specifications Across Scale; and, source of award:
Mixed Sources. Amount of award: $14,778.00. Title:
Interaction of Crystalline Compounds with Porous
Excipients Vis Vapor Phase.
• Diane J. Burgess, principal investigator. Source
of award: PHS/NIH/National Heart, Lung, and
Blood Institute. Amount of award: $6,626.00.
Title: Miniaturized Wireless Implantable Biosensors for Metabolic Monitoring; source of award:
PHS/NIH/NIBIB/Biorasis, Inc. Amount of award:
$123,431.00. Title: Needle-Implantable, and
Wireless Multi-Sensor for Continuous Glucose
Monitoring; source of award: DOD/Army Medical
Research and Material Command. Amount of award:
$490,001.00. Title: Miniaturized Wireless Implantable Biosensors F/Multiple Analyte Monitoring;
source of award: PHS/NIH/National Heart, Lung,
and Blood Institute. Amount of award: $226,335.00.
Title: Miniaturized Wireless Implantable Biosensors
for Metabolic Monitoring; and, source of award:
U.S. Pharmacopeia. Amount of award: $25,000.00.
Title: In Vitro Release Method for Microsphere Stability and Performance Testing.
• Bodhisattwa Chaudhuri, principal investigator.
Source of award: Mixed Sources. Amount of award:
$18,000.00. Title: Numerical Modeling, Optimization, & Scale Up of Pharm. Milling in a Hammer
Mill; source of award: Mixed Sources. Amount of
award: $20,000.00. Title: Numerical Modeling,
Optimization & Scale Up of Pharm. Milling in a
Hammer Mill; and, source of award: Mixed Sources.
Amount of award: $38,000.00. Title: Quantifying
Drying Performance of a Filter Dryer: Experiments
and Stimulation.
• Craig I. Coleman, principal investigator. Source of
award: PHS/Agency for Healthcare Research and
Quality. Amount of Award: $550,000.00. Title:
Acute Coronary Syndrome Thromboectomy Comparative Effectiveness Review.
• Kyle M. Hadden, principal investigator. Source of
award: University of Connecticut Health Center.
43
faculty news
Amount of Award: $30,000.00. Title: Synthesis and
Evaluation of Vitamin D3 Analogues as Inhibitors of
the Oncogenic Hedgehog Signaling Pathway.
• Sean M. Jeffrey, principal investigator. Source of
award: VA/Providence Medical Center. Amount of
Award: $13,610.00. Title: Group Intervention for
Dm Guideline Implementation.
• Devendra S. Kolonia, principal investigator. Source
of award: Genentech, Inc. Amount of Award:
$97,996.00. Title: A Mechanistic Investigation of
Protein-Polyol Interactions; source of award: Genentech, Inc. Amount of award: $80,000.00. Title:
Characterization of Protein Charge Distributions by
Dipole Moment; and, source of award: Genentech,
Inc. Amount of award: $80,000.00. Title: Rheological Characterization of Antibody Solutions.
• John B. Morris, principal investigator. Source of
award: American Petroleum Institute. Amount of
Award: $32,832.00. Title: Upper Respiratory Tract
Uptake of Naphthalene.
• Michael J. Pikal, principal investigator. Source
of award: Mixed Sources. Amount of Award:
$35,000.00. Title: Center for Pharmaceutical Processing Research; source of award: Baxter Healthcare Corporation. Amount of award: $102,715.00.
Title: Investigations Into the Freeze-Drying of OilIn-Water Emulsions as Stable Drug; source of award:
Pharmaceutical Research and Manufacturing of
America. Amount of award: $20,000.00. Title: Critical Factors in Biopreservation of Freeze-Dried Protein Formulations; source of award: Mixed Sources.
Amount of award: $35,000.00. Title: Center for
Pharmaceutical Processing Research; and, source
of award: NIH/Physical Science, Inc. Amount of
award: $115,000.00. Title: Process Endpoint Monitor for Lyophilized Drugs for Cancer Treatment.
• Lauren S. Schlesselman, principal investigator.
Source of award: Future University. Amount of
Award: $446,000.00. Title: Curriculum Development and Assessment for Pharmacy Professional
Degree Program.
• Olga Y. Vinogradova, principal investigator. Source
of award: PHS/NIH/National Heart, Lung, and
Blood Institute. Amount of award: $229,500.00.
Title: Investigation of the Vegfr/Integrin Cytoplasmic
Domains Interaction; source of award: PHS/NIH/
44
National Heart, Lung, and Blood Institute. Amount
of award: $57,375.00. Title: Investigation of the
Vegfr/Integrin Cytoplasmic Domains Interaction;
and, source of award: American Heart Association.
Amount of award: $49,500.00. Title: Structural Insights into the Skelemin Regulate Integrin Function.
• Charles M. White, principal investigator. Source
of award: PHS/Agency for Healthcare Research
and Quality. Amount of award: $17,019.00. Title:
Treatments for Epilepsy; and, source of award:
PHS/Agency for Healthcare Research and Quality.
Amount of award: $577,982.00. Title: Treatments
for Epilepsy.
• Dennis L. Wright, principal investigator. Source
of award: Promiliad Biopharma, Inc. Amount of
Award: $50,425.00. Title: New Antibiotic Targeting
Fatty Acid Biosynthesis.
University of Florida
• Joseph A. Delaney, assistant professor
• Carinda Field, clinical associate professor
• Anna Hall, clinical assistant professor
• Heather Hardin, clinical assistant professor
• Carrie Haskell-Luevano was appointed to the
editorial advisory board of the Journal of Medicinal
Chemistry.
• Teresa L. Kauf was appointed to a four-year term
as co-editor and member of editorial board of the
journal, Value in Health.
• John S. Markowitjjz, professor
• Folakemi Odedina, professor of pharmaceutical
outcomes & policy
• Teresa Roane, clinical assistant professor
• Burcin Unel, clinical assistant professor
• Katie Vogle-Anderson, clinical assistant professor
• Haojie Zhu, assistant research professor
faculty news
Awards
• Jason Frazier received a University of Florida
2010-11 Jack Wessel Excellence Award for Assistant
Professors, a one-time productivity award of $5,000
in support of young researchers.
• Ann M. Snyder is the first pharmacist to receive the
University of Florida College of Medicine Master
Educator Fellowship certificate.
Grants
• Michael J. Katovich has been awarded a five-year
NIH award for $2.5M from the National Heart,
Lung and Blood Institute for “Angiotensin-Converting Enzyme2 in Vascular Endothelial Function.”
• Almut G. Winterstein has received a two-year
$482,000 award from the Agency for Healthcare
Research and Quality for “Comparative Safety and
Effectiveness of Stimulants in Medicaid Youth with
ADHD.” This year she was also chosen as one of the
University of Florida Research Foundation Professors for 2010-2013 and will receive a $5,000 annual
salary supplement and a $3,000 grant to support
her research in pharmacoepidemiology and patient
safety.
Promotions
• Jason Frazier, associate professor of pharmacodynamics
• Bin Liu, associate professor of pharmacodynamics
• Hendrik Luesch, associate professor of medicinal
chemistry
Retirements
• Gerald E. Gause, associate scholar in pharmacodynamics
• Robert L. Emerson Jr. has been appointed clinical
associate professor and director, ambulatory based
advanced pharmacy practice experiences in clinical
sciences & administration department.
• Bradley K. McConnell has been appointed to the
editorial board of Clinical and Experimental Hyper-
tension.
• Vincent H. Tam has been re-appointed to the editorial board of Antimicrobial Agents and Chemotherapy.
• Meghana Trivedi has been appointed assistant professor in clinical sciences & administration.
Awards
• Kimberly K. Birtcher has been named the Gulf Coast
Society of Health-System Pharmacists’ 2010 Outstanding Pharmacist.
• Elizabeth A. Coyle has been elected Fellow of the
American College of Critical Care Medicine.
• Mustafa F. Lokhandwala has been elected Fellow of
the American Society of Nephrology.
Grants
• Hua Chen has received a one-year, $60,000 Research Starter Grant in Health Outcomes from the
Pharmaceutical Manufacturers of America Foundation for her project, “The Definition, Utilization and
Development of Long-term Psychotropic Polypharmacy in Children and Adolescents.”
• Diana S-L. Chow has received a $45,000 grant
from the Gillson Longenbaugh Foundation for her
“Transdermal Delivery of Lactone-stabilized Camptothecin Derivative for Breast Cancer Treatment.”
• Joydip Das has received a three-year, $450,000 grant
from the National Institute on Alcohol Abuse and
Alcoholism for “Role of Protein Kinase C Regulatory
Domains in Modulating Alcohol Actions.”
• Kevin W. Garey has received a two-year, $80,140
grant from Merck & Co. for “Susceptibility and
Recurrence of Candida Species Before and After a
Formulary Change from Caspofungin to Micafungin
in Patients with Candidemia.”
• Ming Hu has received a $1.1 million subcontract
award (in collaboration with Washington University) from the National Institute for Complementary
and Alternative Medicine for “Chemoprevention of
Lung Cancer with Red Ginseng Extracts.”
• Vincent H. Tam has received a three-year, $450,000
grant from the National Institute of Allergy and
Infectious Diseases for “Clinical Pharmacology of
Polymyxin B.”
45
faculty news
• Rosa F. Yeh and Ming Hu have received a three-year,
$113,537 subcontract award (in collaboration with
Baylor College of Medicine and University of Texas)
from the National Institute for Complementary and
Alternative Medicine for “Phase I Study to Evaluate Safety and Toxicity of EGCG in HIV-1-Infected
Individuals.”
The University of Iowa
• Jay D. Currie was selected as chair-elect of the
American Pharmacists Association-Academy of
Pharmacy Practice and Management (APPM) Section of Community and Ambulatory Practice for
2010-2011.
Awards
• Paul N. Abramowitz is the recipient of the 2010
Distinguished Alumni Award of the University of
Michigan College of Pharmacy.
• William R. Doucette was selected as an American
Pharmacists Association Fellow.
• Michael W. Duffel has been named the 2010 Regents
Award for Faculty Excellence.
• James A. Ponto received the American Pharmacists
Association-Academy of Pharmacy Practice and
Management (APhA-APPM) Presentation Merit
Award for his poster presentation titled “Evaluation
of Alternative Methods for Radiochemical Purity
Testing of In-111 Capromab Pendetide.”
ciation of Chain Drug Stores-American Foundation
for Pharmaceutical Education Pharmacy Faculty
Development Fellowship in Community Practice.
• Jeffrey Gonzalez was named Faculty Preceptor of the
Year by the graduating Class of 2010.
• Jill A. Morgan was named Faculty Member of the
Year by the graduating Class of 2010.
• The Maryland P3 Program (Patients, Pharmacists,
Partnerships), under the direction of Magaly Rodriguez de Bittner, received the American Pharmacists
Association Foundation’s Pinnacle Award Group
Practice/Health System/Corporation Category.
• Sheila Weiss Smith received the 2010 University of
Maryland, Baltimore Patricia Sokolove Outstanding Mentor Award for her dedication and effort in
mentoring graduate and professional students.
Grants
• Lisa Charneski received $100,256 from Suburban
Hospital for “Innovative Pharmacotherapy Services.”
• Amy Davidoff received $423,000 from the American
Cancer Society for “Supplemental Medical and Drug
Insurance and Cancer-related Spending.”
• Mary Lynn McPherson received $50,000 from King
Pharmaceuticals for “Development of a Monograph
on Pain Management, Focusing on REMS (Risk
Evaluation and Mitigation Strategies).”
• Meghan K. Sullivan received $170,640 from Safeway, Inc., for “Safeway Wellness Prevention Program.”
• Bernard A. Sorofman has been selected as one of the
2010 recipients of the Michael J. Brody Award for
Faculty Excellence in Service.
• Hongbing Wang received $21,000 from BASF SE for
“Mechanistic Studies of Direct CAR Activation.”
University of Maryland
• Bruce Yu received $18,906 from the University of
Maryland, College Park for “Force Sensitive NanoNetworks.”
• James E. Polli was appointed to the Food and Drug
Administration’s Pharmaceutical Science and Clinical Pharmacology Advisory Committee for a fouryear term.
Awards
• Lauren B. Angelo received the 2010 National Asso-
46
Promotions
• Sarah L. Michel has been promoted to associate
professor with tenure in the Department of Pharmaceutical Sciences.
• Jill A. Morgan has been promoted to associate professor in the Department of Pharmacy Practice and
Science.
faculty news
• C.S. Raman has been promoted to associate professor with tenure in the Department of Pharmaceutical Sciences.
• Jon C. Schommer is PI on a $30,438 grant from Anthurium Solutions, Inc. for the “Project to Develop
a Voice-Activated Pharmacy/Patient Consultation
System to Support Medication Therapy Management Delivery and Billing Services.” Co-investigators are Chrystian R. Pereira and Sarah M. Westberg,
and consultant is Lowell J. Anderson.
• Ling Li will join the University of Minnesota College
of Pharmacy on July 26 as the VFW endowed chair pharmacotherapy for the elderly.
University of Missouri–
Kansas City
• Carston (Rick) Wagner is the first to hold the endowed chair in medicinal chemistry.
Awards
Grants
• Richard C. Brundage is the recipient of a Pfizer Fellowship in Pharmacometrics award. The award will
pay $220,000 over five years ($55,000 per year) to
support graduate students in pharmacometrics.
• Each of the following received a $30,000 Engebretson Drug Design & Development Grant: Vekatram
R. Mereddy for his project, “Development of Novel
Small Molecule MCT1 Inhibitors as Anti-Cancer
Agents”; and Daniel A. Harki for his project, “Development of L-Nucleoside Anticancer Agents.”
• Keri H. Naglosky, Marcia M. Worley, Timothy P.
Stratton and Randall D. Seifert received a $63,000
grant for their study, “Pilot Study to Determine the
Effectiveness of Pharmacist Provided MTM Using
Face-to-Face and TeleMTM in the Treatment of
Long-Haul Drivers with Hypertension Department
of Transportation Classifications Stage 1, 2 and 3.”
• Jayanth Panyam received a $26,996 grant from the
Randy Shaver Cancer Research and Community
Fund in support of his project, “Dual Targeted
Multifunctional Nanoparticles for the Treatment of
Brain Tumors.”
• Ronald J. Sawchuk and Belinda Cheung received
new funding of $299,969 from Alcon Labs for the
continuation of their project, “Testing the Penetration of Moxifloxacin into Chinchilla Middle Ear
using Transtympanic Membrane Delivery Formulation” through Dec. 31, 2010. Alcon Labs has also
agreed to retain an option to license the patented
technology for an additional sum of $50,000.
• The UMKC School of Pharmacy has announced the
receipt of an estate gift commitment from Robert
Sperry, a local resident whose family has longtime
ties to the pharmacy industry. Sperry has requested
that the gift be used to fund the creation of an
endowed chair in geriatric pharmacotherapy and to
support School of Pharmacy students through the
UMKC Pharmacy Foundation.
The University of Montana
Grants
• John M. Gerdes and Richard J. Bridges have been
awarded $199,995 from the Robert Packard Center
for ALS Research for Cerebral PET Imaging Agents
for Monitoring ALS Therapy and Astroglia: from
Chemicals to Rodents to Humans.
• Andrij Holian has been awarded $10,883 from
Montana State University for Remote Detection of
Chemicals Associated with Clandestine Drug Labs.
• Kendra Procacci has been awarded $100,000 from
the Montana Department of Public Health and Human Services for Implementing Asthma Clinics in
Community Pharmacies.
• Andrea Stierle has been awarded $542,136 from
NIH to study Signal Transduction Enzyme Inhibitors
from Extremophilic Microbes as Anticancer Agents.
• Andrea Stierle and Donald Stierle have been awarded $15,000 from Montana State University for Novel
Antifungal Agents from Acid Mine Waste Microbes.
47
faculty news
University of North Carolina
at Chapel Hill
on Instructional Excellence Innovation in Education
Award for “A Novel Approach to Teaching Clinical
Decision-Making Using Virtual Patient Technology.”
Grants
• Lauren J. Jonkman received board certification as a
pharmacotherapy specialist (BCPS).
• David S. Lawrence and Vyas Sharma, Bill & Melinda
Gates Foundation, $100,000, Instrument-free detection of DNA disease markers.
• Joanne G. Kowiatek was named a Fellow of the
American Society of Health-System Pharmacists.
Promotions
• Brian A. Potoski received the 2010 Faculty Preceptor of the Year Award.
• Russell J. Mumper, executive associate dean for
academics
Retirements
• Kristine S. Schonder was selected as the recipient
of the 2010 Stanford I. Cohen Teacher of the Year
Award.
• Anthony J. Hickey, professor
Grants
• Robert B. Gibbs received a three-year, $399,989
grant from the National Science Foundation for
“Role of GPR30 in Estrogen-Mediated Effects on
Cholinergic Function and Cognition.”
• Sandra L. Kane-Gill has been appointed co-chair of
the Society of Critical Care Medicine Program Committee for Congress in 2012.
• Song Li was appointed to serve as a member of the
National Institutes of Health Developmental Therapeutics Study Section, Center for Scientific Review,
for a three-year term.
• Dexi Liu was appointed to serve as chair of the
American Society of Gene & Cell Therapy Membership Committee for a one-year term.
• Susan M. Meyer was appointed to represent the
profession of pharmacy on the Interprofessional
Collaborative Practice and Education Panel. She
has been elected to a second three-year term on the
Board of Directors of the Association for Prevention
Teaching and Research and has also been elected as
Region II East Coast Region Councilor for the Rho
Chi Society.
• Wen Xie received a five-year, $1.6 million National
Institutes of Health grant for “A Novel Role of the
Aryl Hydrocarbon Receptor in Hepatic Steatosis.”
He also received an $83,582 supplement from the
National Institutes of Health for his existing grant,
“Regulation of Sulfotransferases by LXR and Its
Implication in Pathophysiology.”
Promotions
• Levent Kirisci, professor of pharmaceutical sciences
• Lisa C. Rohan, associate professor of pharmaceutical
sciences with tenure
• Michael M. Vanyukov, professor of pharmaceutical
sciences
• Taira Wada, instructor of pharmaceutical sciences
The University of Tennessee
• Samuel M. Poloyac was co-chair of the Society of
Critical Care Medicine Meeting, Clinical Focus on
Hypothermia: Keeping It Cool - How to Implement
Hypothermia in Your Clinical Practice.
Awards
• Peter A. Chyka was installed as a distinguished practitioner member of the Pharmacy Academy of the
National Academies of Practice.
• Neal J. Benedict, along with colleagues in the School
of Medicine, received a Provost’s Advisory Council
48
• Lawrence M. Brown was installed as a Trustee of
APhA in March 2010.
faculty news
• Stephanie J. Phelps was installed in March 2010 as
chair of the National Academies of Practice Pharmacy Academy.
Grants
• Candace S. Brown, Boehringer Ingelheim, Filbanserin in postmenopausal women with hypoactive
sexual desire disorder.
• Lawrence M. Brown, NACDS Foundation, Services
for the creation of a Web-based patient care database.
• Trevor McKibbin, UT Cancer Institute, Protein
changes within P13-Akt-mTOR and EGFR pathways.
• P. David Rogers, NIH, Novel Azole Resistance
Mechanisms of Candida albicans.
• Michael C. Storm, UT Research Foundation, Pediatric dosage of Omega-3 Polyunsaturated Fatty Acids.
• Michelle M. Zingone, State of Tennessee, Pharmacist-Physician Collaboration for Diabetes Care.
Awards
• Vincent F. Mauro was awarded the Outstanding
Teacher of the Year by the 2010 Doctor of Pharmacy
class.
The University of Utah
• Diana I. Brixner has been appointed to the Board
of the Academy of Managed Care Pharmacists
(AMCP) for a second year.
Awards
• Diane Ogborn (P2) and her mentor, Karen M.
Gunning, received a scholarship for the 2010 AACP
Wal-Mart Scholars Program.
University of Washington
Awards
• The School of Pharmacy’s Pharmaceutical Out-
comes Research and Policy Program (PORPP) is a
founding member of the UW Centers for Comparative and Health Systems Effectiveness (CHASE)
Alliance.
Grants
• Kenneth E. Thummel received a multi-million dollar
U01 grant to create a new Center on Pharmacogenetics in Rural and Underserved Populations. Thummel will be the co-principal investigator of the grant
with a professor in the UW School of Medicine.
Promotions
• Isabelle Ragueneau-Majlessi has joined the Department of Pharmaceutics faculty as a clinical associate
professor. She also became director of the School of
Pharmacy’s Metabolism and Transport Drug Interaction Database.
Virginia Commonwealth
University
• Daniel Adkins was named assistant professor.
• Gretchen Brophy was appointed to the American
College of Critical Care Medicine Nominating Committee.
• Laura A. Morgan was named director of the School
of Pharmacy’s Foundations Lab.
• Renee Murray was appointed to a three-year term on
the Editorial Advisory Board of Pharmacy Today.
• James X. Zhang was cross-appointed as an affiliate
faculty member in the VCU School of Medicine’s
Department of Epidemiology and Community
Health. He also was appointed to the Scientific Committee of the American Society of Health Economists.
Awards
• Umesh R. Desai received the School of Pharmacy’s
2010 Faculty Award for Excellence in Teaching.
• Jean-Venable “Kelly” R. Goode was one of 14
pharmacy professionals inducted into the National
Academies of Practice as a 2010 Distinguished Prac-
49
faculty news
titioner and Scholar.
• Gary R. Matzke was among the inaugural class of
fellows inducted into the National Academies of
Practice.
• The School of Pharmacy’s Pharmacist Collaborative Care in the Community program—represented
by Akash J. Alexander, Sallie D. Mayer, Gary R.
Matzke, Leticia R. Moczygemba, Amy Rudenko and
Evan Sisson—won the university’s 2010 Currents
of Change Award for overall excellence in community engagement. The School of Pharmacy also was
named as participant in two 2010–11 community
partnership programs: “Improving Access and Quality of Care for the Medically Underserved Through
the Interdisciplinary Enhanced Teaching Model”
and “Una Vida Sana: Assessing and Improving the
Health Status of Richmond’s Hispanic Community
Through Health Professional Service Learning.”
• Thomas P. Reinders received the 2010 Robert J.
DeSalvo Distinguished Alumnus Award during the
University of Cincinnati’s James L. Winkle College
of Pharmacy Hooding and Recognition Ceremony in
June.
Grants
• Mary Jayne Kennedy, $263,462 grant from the
Commonwealth Health Research Board for “Evaluation of mitochondrial gene sequence variants as
biomarkers of aminoglycoside-induced renal injury
in newborn infants.”
• Patricia W. Slattum (co-PI), $1,250,000 NCRR
(R25) grant from the National Institutes of Health
for “Project CRESST: Clinical Research Education
for Science Students and Teachers.”
Washington State University
• R. Keith Campbell, appointed, editorial board of
World Journal of Diabetes
• Lawrence J. Cohen, elected to National Academies
of Practice; appointed, editorial board of Psychiatry
2010
• Joshua J. Neumiller, appointed, editorial board of
World Journal of Diabetes
50
• Gary M. Pollack, new dean of the College of Pharmacy
Awards
• Joshua J. Neumiller was awarded a faculty development fellowship in geriatric pharmacy from American Foundation for Pharmaceutical Education,
$25,000.
Wayne State University
• Hossam M. Ashour, assistant professor of pharmacy
practice
• Fei Chen, associate professor of pharmaceutical
sciences
• Christopher Guiliano, assistant professor of pharmacy practice
• Emily Martin, assistant professor of pharmacy
practice
• Anna Moszczynska, assistant professor of pharmaceutical sciences
Grants
• Michael J. Rybak and Celine Vidaillac, Cerexa
Pharmaceuticals/Forest Laboratories, $81,092, In
vitro pharmacokinetic/pharmacodynamic (PK/PD)
evaluation of ceftaroline versus ceftriaxone against
clinical isolates of Streptococcus pneumoniae with
differing susceptibility to cephalosporins.
• Michael J Rybak, Cerexa, Inc.,$81,092, In Vitro
Pharmacokinetic/Pharmacodynamic (PK/PD)
Evaluation of Ceftaroline versus Ceftriaxone Against
Clinical Isolates of Streptococcus Pneumoniae with
Differing Susceptibility to Cephalosporins.
• Patrick M. Woster, $1,311,950 for five years from
the National Institutes of Health/National Cancer
Institute, Identification of LSD1 inhibitors targeting
epigenetic regulation in tumor cells.
Promotions
• Steve Firestine, promotion and tenure to associate
professor of pharmaceutical sciences
faculty news
Retirements
• Paul J. Munzenberger, associate professor of pharmacy practice
West Virginia University
• Marie A. Abate and Arthur I. Jacknowitz were reappointed to the NAPLEX Review Committee for the
term 2010-2013.
• Arthur I. Jacknowitz served as chair of the Committee of Tellers at the 2010 USP Convention and was
recognized for 30 years of service to USP and his attendance at 6 consecutive conventions (1985-2010).
• Kimberly Kelly was appointed associate professor
in the Department of Pharmaceutical Systems and
Policy.
• Virginia Scott was selected as the AACP Council of
Faculties chair-elect.
• Letha Sooter was appointed assistant professor in
the Department of Basic Pharmaceutical Sciences.
• Ashlee McMillan was appointed clinical assistant
professor and director of skills development.
Awards
• Usha Sambamoorthi was the recipient of the Steven Banks Award for Mentoring in Mental Health
Research.
• Terry L. Schwinghammer was selected as a Fellow
in the American Pharmacists Association (APhA)
Academy of Pharmacy Practice and Management.
Retirements
• Gretchen Kreckel was appointed clinical assistant
professor in the Department of Clinical Pharmacy.
• Joseph K.H. Ma, professor in the WVU School of
Pharmacy Department of Basic Pharmaceutical Sciences, retired in June after 34 years of outstanding
service to West Virginia University.
• John (Jay) Martello was appointed clinical assistant
professor in the Department of Clinical Pharmacy.
Emerging Schools
• Xiaoyun Pan was appointed assistant professor in
the Department of Pharmaceutical Systems and
Policy.
Manchester College
• Charles D. Ponte was appointed to the editorial
board for Pharmacotherapy, the official journal of
the American College of Clinical Pharmacy.
• Philip J. Medon will join Manchester College as vice president and dean of the School of Pharmacy. He also will
serve as a professor of pharmacy and toxicology.
• W. Clarke Ridgway was elected interim treasurer of
the American Institute of the History of Pharmacy.
• Usha Sambamoorthi was appointed professor in the
Department of Pharmaceutical Systems and Policy.
Remember to submit your Faculty News today!
It’s fast and easy to make sure your college or school of pharmacy is
featured in the Faculty News section of Academic Pharmacy Now.
Visit the AACP Web site at www.aacp.org and complete the School News
Submission Form on the News and Publications portion of the Web site.
51
1727 King Street · Alexandria, VA 22314
p: 703-739-2330 · f: 703-836-8982 · www.aacp.org
For address change, please return mailing label with current school affiliation.
Watch Your Mailbox!
In October, your college or
school of pharmacy will
be receiving your American Pharmacy Educator
Week toolkit. It contains
a myriad of resources
designed to help you
implement inventive
ways to encourage students to consider careers
in academic pharmacy.
American Pharmacy Educator Week materials will
also be available for download on the AACP Web site
by visiting www.aacp.org/
career/facultyrecruitment/apew.
Don’t forget to submit your activities for inclusion in an upcoming issue of Academic Pharmacy Now. E-mail [email protected]
with stories and photos of how you celebrated the discoveries and accomplishments of America’s pharmaceutical scientists and educators.
How will you celebrate?
October 24–30, 2010

pdf version

Transcription

Similar documents

PDF - First Nations Health Authority

FMP Direct Service

Qmatic Pharmacy - Customer Flow Management

PharmacistsBargainin..

3 - BP Healthcare

HM HOME CARE

Harding Students Lobbied for Arkansas Therapeutic Substitution Law

QPLN WP-3 - Carol Davila

Pharmacies